Cheng Cameron Yin, M.D., Ph.D.

Peer-Reviewed Articles

1. Manshouri T, Veletic I, Li P, Yin CC, Post SM, Verstovsek S, Estrov Z. GLI1 Activates Pro-Fibrotic Pathways in Myelofibrosis Fibrocytes. Cell Death Dis 13(5):481, 2022. e-Pub 2022. PMID: 35595725.
2. Mankar R, Gajjela CC, Bueso-Ramos CE, Yin CC, Mayerich D, Reddy RK. Polarization sensitive photothermal mid-infrared spectroscopic imaging of human bone marrow tissue. Appl Spectrosc 76(4):508-518, 2022. e-Pub 2022. PMID: 35236126.
3. Zhao M, Medeiros LJ, Wang W, Tang G, Jung HS, Sfamenos SM, Fang H, Toruner GA, Hu S, Yin CC, Lin P, Gu J, Peng G, You MJ, Khoury JD, Wang SA, Tang Z. Newly Designed Breakapart FISH Probe Helps to Identify Cases with True MECOM Rearrangement in Myeloid Malignancies. Cancer Genet 262-263:23-29, 2022. e-Pub 2021. PMID: 34974290.
4. Khanlari M, Medeiros LJ, Lin P, Xu J, You MJ, Tang G, Yin CC, Wang W, Qiu L, Miranda RN, Bueso-Ramos CE, Li S. Blastoid High Grade B-cell Lymphoma Initially Presenting in Bone Marrow: A Diagnostic Challenge. Mod Pathol 35(3):419-426, 2022. e-Pub 2021. PMID: 34608246.
5. Khanlari M, Li S, Miranda RN, Iyer S, Konoplev S, Lin P, Yin CC, Tang G, Qiu L, Vega F, Medeiros LJ, Xu J. Small cell/lymphohistiocytic morphology is associated with peripheral blood involvement, CD8 positivity and retained T cell antigens, but not outcome in adults with ALK+ anaplastic large cell lymphoma. Mod Pathol 35(3):412-418, 2022. e-Pub 2021. PMID: 34628481.
6. Khanlari M, Wang X, Loghavi S, Wang SA, Li S, Thakral B, Bueso-Ramos CE, Yin CC, Kanagal-Shamanna R, Khoury JD, Patel KP, Popat UR, Medeiros LJ, Konoplev S. Value and Pitfalls of Assessing Bone Marrow Morphologic Findings to Predict Response in Patients with Myelofibrosis Who Undergo Hematopoietic Stem Cell Transplantation. Ann Diagn Pathol 56:151860, 2022. e-Pub 2021. PMID: 34823075.
7. Qiu L, Xu J, Tang G, Wang SA, Lin P, Ok CY, Garces S, Yin CC, Khanlari M, Vega F, Medeiros LJ, Li S. Mantle Cell Lymphoma with Chronic Lymphocytic Leukemia-Like Features: A Diagnostic Mimic and Pitfall. Hum Pathol 119:59-68, 2022. e-Pub 2021. PMID: 34767860.
8. Yang RK, Toruner GA, Wang W, Fang H, Issa GC, Wang L, Quesada AE, Thakral B, Patel KP, Peng G, Liu S, Yin CC, Borthakur G, Tang Z, Wang SA, Miranda RN, Khoury JD, Medeiros LJ, Tang G. CBFB Break-Apart FISH Testing: An Analysis of 1629 AML Cases with a Focus on Atypical Findings and Their Implications in Clinical Diagnosis and Management. Cancers (Basel) 13(21), 2021. e-Pub 2021. PMID: 34771519.
9. Richard-Carpentier G, Kantarjian HM, Tang G, Yin CC, Khoury JD, Issa GC, Haddad FG, Jain N, Ravandi F, Short NJ, DiNardo CD, Takahashi K, Konopleva MY, Daver NG, Kadia TM, Garcia-Manero G, Garris R, O'Brien SM, Jabbour EJ. Outcomes of Acute Lymphoblastic Leukemia with KMT2A (MLL) rearrangement - The MD Anderson Experience. Blood Adv. e-Pub 2021. PMID: 34525185.
10. Wang L, Tang G, Medeiros LJ, Xu J, Huang W, Yin CC, Wang M, Jain P, Lin P, Li S. MYC rearrangement but not extra MYC copies is an independent prognostic factor in patients with mantle cell lymphoma. Haematologica 106(5):1381-1389, 2021. e-Pub 2021. PMID: 32273477.
11. Jain P, Kanagal-Shamanna R, Zhang S, Ok CY, Navsaria L, Nastoupil L, Lee HJ, Tang G, Yin CC, Badillo M, Nair R, Li S, Patel KM, Flowers C, Vega F, Wang L, Wang ML. Outcomes of relapsed mantle cell lymphoma patients after discontinuing acalabrutinib. Am J Hematol 96(5):E137-E140, 2021. e-Pub 2021. PMID: 33491779.
12. Lyapichev KA, Tang G, Li S, You MJ, Cheng TJ, Miranda RN, Iyer S, Yin CC, Konoplev S, Bueso-Ramos C, Vega F, Medeiros LJ, Xu J. MYC expression is associated with older age, common morphology, increased MYC copy number, and poorer prognosis in patients with ALK+ anaplastic large cell lymphoma. Hum Pathol 108:22-31, 2021. e-Pub 2020. PMID: 33221344.
13. Khanlari M, Tang G, Hao S, Gong Y, Li S, Miranda RN, Lin P, Iyer S, Yin CC, Xie W, Vega F, Medeiros LJ, Xu J. Anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma with MYC rearrangement. Br J Haematol 192(1):e17-e21, 2021. e-Pub 2020. PMID: 33216956.
14. Alotaibi AS, Abdulrazzaq M, Patel KP, Ravandi F, Konoplev S, Bueso-Ramos C, Yin CC, Muzzafar T, Tang G, Futreal A, Jain N, Konopleva MY, Pemmaraju N. Acute promyelocytic leukemia (APL) with an IRF2BP2-RARA fusion transcript: an aggressive APL variant. Leuk Lymphoma 61(12):3018-3020, 2020. e-Pub 2020. PMID: 32657180.
15. Tang Z, Toruner GA, Tang G, Yin CC, Wang W, Hu S, Thakral B, Wang SA, Miranda RN, Khoury JD, Medeiros LJ. Chronic myeloid leukemia with insertion-derived BCR-ABL1 fusion: redefining complex chromosomal abnormalities by correlation of FISH and karyotype predicts prognosis. Mod Pathol 33(10):2088, 2020. PMID: 32737448.
16. Lyapichev KA, Sakhdari A, Khoury JD, O'Malley DP, El Hussein S, Yin CC, Patel KP, Thakral B, Young KH, Medeiros LJ, Konoplev S. Lymphoid Enhancer Binding Factor 1 (LEF1) Expression is Significantly Higher in Hodgkin Lymphoma Associated with Richter Syndrome Relative to de novo Classic Hodgkin Lymphoma. Ann Diagn Pathol 49:151636. e-Pub 2020. PMID: 32977233.
17. Yilmaz M, Kantarjian HM, Toruner G, Yin CC, Kanagal-Shamanna R, Cortes JE, Issa G, Short NJ, Khoury JD, Garcia-Manero G, Ravandi F, Kadia T, Konopleva M, Wierda WG, Jain N, Estrov Z, Sasaki K, Pierce S, O'Brien SM, Jabbour EJ. Translocation t(1;19)(q23;p13) in adult acute lymphoblastic leukemia - a distinct subtype with favorable prognosis. Leuk Lymphoma:1-5. e-Pub 2020. PMID: 32955970.
18. Xie W, Medeiros LJ, Li S, Yin CC, Khoury JD, Xu J. PD-1/PD-L1 Pathway and its Blockade in Patients with Classic Hodgkin Lymphoma and Non-Hodgkin Large Cell Lymphomas. Curr Hematol Malig Rep 15(4):372-381, 2020. PMID: 32394185.
19. Garces S, Yin CC, Miranda RN, Patel KP, Li S, Xu J, Thakral B, Poppiti RJ, Medina AM, Sriganeshan V, Castellano-Sánchez A, Khoury JD, Garces JC, Medeiros LJ. Clinical, Histopathologic and Immunoarchitectural Features of Dermatopathic Lymphadenopathy: An Update. Mod Pathol 33(6):1104-1121, 2020. e-Pub 2020. PMID: 31896812.
20. Wu L, Xia M, Sun X, Han X, Zu Y, Jabbour EJ, You MJ, Lin P, Li S, Xu J, Han H, Bueso-Ramos CE, Medeiros LJ, Qiu X, Yin CC. High levels of immunoglobulin expression predict shorter overall survival in patients with acute myeloid leukemia. Eur J Haematol. e-Pub 2020. PMID: 32535947.
21. Zhao S, Kanagal-Shamanna R, Navsaria L, Ok CY, Zhang S, Nomie K, Han G, Hao D, Hill HA, Jiang C, Yao Y, Nastoupil L, Westin J, Fayad L, Nair R, Steiner R, Ahmed S, Samaniego F, Iyer SP, Oriabure O, Chen W, Song X, Zhang J, Badillo M, Moghrabi O, Aranda J, Tang G, Yin CC, Patel K, Medeiros LJ, Li S, Vega F, Thirumurthi S, Xu G, Neelapu S, Flowers CR, Romaguera J, Fowler N, Wang L, Wang ML, Jain P. Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients. Am J Hematol 95(6):623-629, 2020. e-Pub 2020. PMID: 32239765.
22. Gong Z, Zhou T, Liu H, Tang G, Yin CC, Wang W, Medeiros LJ, Hu S. Genotype-phenotype correlation of unusual BCR-ABL1 transcripts in Philadelphia chromosome-positive leukaemia. Br J Haematol 189(5):e207-e211, 2020. e-Pub 2020. PMID: 32237084.
23. Li N, Ma Y, Wang W, Yin CC, Wu W, Sun R, Zhao G, Li S, Wang X. LOC101928834, a novel lncRNA in Wnt/β-catenin signaling pathway, promotes cell proliferation and predicts poor clinical outcome in myelodysplastic syndromes. Clin Sci (Lond) 134(11):1279-1293, 2020. PMID: 32463458.
24. Shen J, Medeiros LJ, Li S, Wang SA, Lin P, Khanlari M, Iyer SP, Yin CC, Tang G, Jorgensen JL, Hu S, Miranda RN, Xu J. CD8 expression in anaplastic large cell lymphoma correlates with noncommon morphologic variants and T-cell antigen expression suggesting biological differences with CD8-negative anaplastic large cell lymphoma. Hum Pathol 98:1-9, 2020. e-Pub 2020. PMID: 32032618.
25. Xu J, Liu JL, Medeiros LJ, Huang W, Khoury JD, McDonnell TJ, Tang G, Schlette E, Yin CC, Bueso-Ramos CE, Lin P, Li S. MYC rearrangement and MYC/BCL2 double expression but not cell-of-origin predict prognosis in R-CHOP treated diffuse large B-cell lymphoma. Eur J Haematol 104(4):336-343, 2020. e-Pub 2020. PMID: 31944390.
26. Xie W, Tang G, Li S, Yin CC, Xu J. Anaplastic multiple myeloma resembling dysplastic megakaryocytes. Clin Case Rep 8(3):568-569, 2020. e-Pub 2019. PMID: 32185061.
27. Shen J, Li S, Medeiros LJ, Lin P, Wang SA, Tang G, Yin CC, You MJ, Khoury JD, Iyer SP, Miranda RN, Xu J. PD-L1 expression is associated with ALK positivity and STAT3 activation, but not outcome in patients with systemic anaplastic large cell lymphoma. Mod Pathol 33(3):324-333, 2020. e-Pub 2019. PMID: 31383967.
28. Jain P, Zhang S, Kanagal-Shamanna R, Ok CY, Nomie K, Gonzalez GN, Gonzalez-Pagan O, Hill HA, Lee HJ, Fayad L, Westin J, Nastoupil L, Hagemeister F, Chen W, Oriabure O, Badillo M, Jiang C, Yixin Y, Li S, Tang G, Yin CC, Patel KP, Medeiros LJ, Nair R, Ahmed S, Iyer SP, Thirumurthi S, Champlin R, Xu G, Tinsu P, Santos D, Wang R, Han G, Zhang J, Song X, Neelapu S, Romaguera J, Futreal A, Flowers C, Fowler N, Wang L, Wang ML. Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL. Blood Adv 4(6):1038-1050, 2020. PMID: 32191807.
29. Sakhdari A, Thakral B, Loghavi S, Kanagal-Shamanna R, Yin CC, Zuo Z, Routbort MJ, Luthra R, Medeiros LJ, Wang SA, Patel KP, Ok CY. RAS and TP53 can predict survival in adults with T-cell lymphoblastic leukemia treated with hyper-CVAD. Cancer Med 9(3):849-858, 2020. e-Pub 2019. PMID: 31804006.
30. Mankar R, Bueso-Ramos CE, Yin CC, Hidalgo-Lopez JE, Berisha S, Kansiz M, Mayerich D. Automated osteosclerosis grading of clinical biopsies using infrared spectroscopic imaging. Anal Chem. e-Pub 2019. PMID: 31793292.
31. Hu B, Patel KP, Chen HC, Wang X, Luthra R, Routbort MJ, Kanagal-Shamanna R, Medeiros LJ, Yin CC, Zuo Z, Ok CY, Loghavi S, Tang G, Tambaro FP, Thompson P, Burger J, Jain N, Ferrajoli A, Bose P, Estrov Z, Keating M, Wierda WG. Association of Gene Mutations with Time-to-First Treatment in 384 Treatment-Naive Chronic Lymphocytic Leukaemia Patients. Br J Haematol 187(3):307-318, 2019. e-Pub 2019. PMID: 31243771.
32. Bah I, Li S, Yin CC, Tang G, Xu J. Merkel cell carcinoma mimicking transformed chronic lymphocytic leukemia/small lymphocytic lymphoma. Clin Case Rep 7(11):2256-2257, 2019. e-Pub 2019. PMID: 31788294.
33. Sukswai N, Aung PP, Yin CC, Li S, Wang W, Wang SA, Ortega V, Lyapichev K, Nagarajan P, Alfattal R, Angelova E, Tang Z, Loghavi S, Kanagal-Shamanna R, Miranda RN, Pemmaraju N, Bhalla K, Konopleva M, Medeiros LJ, Khoury JD. Dual Expression of TCF4 and CD123 is Highly Sensitive and Specific for Blastic Plasmacytoid Dendritic Cell Neoplasm. Am J Surg Pathol 43(10):1429-1437, 2019. PMID: 31261288.
34. Miao Y, Lin P, Saksena A, Xu J, Wang M, Romaguera J, Yin CC, Medeiros LJ, Li S. CD5-negative mantle cell lymphoma: clinicopathologic correlations and outcome in 58 patients. Am J Surg Pathol 43(8):1052-1060, 2019. PMID: 31045891.
35. Sakhdari A, Ok CY, Patel KP, Kanagal-Shamanna R, Yin CC, Zuo Z, Hu S, Routbort MJ, Luthra R, Medeiros LJ, Khoury JD, Loghavi S. TP53 Mutations are Common in Mantle Cell Lymphoma, Including the Indolent Leukemic Non-Nodal Variant. Ann Diagn Pathol 41:38-42, 2019. e-Pub 2019. PMID: 31132650.
36. Saksena A, Yin CC, Xu J, Li J, Zhou J, Wang SA, Lin P, Tang G, Wang L, Wang M, Miranda RN, Medeiros LJ, Li S. CD23 expression in mantle cell lymphoma is associated with CD200 expression, leukemic non-nodal form and a better prognosis. Hum Pathol 89:71-80, 2019. e-Pub 2019. PMID: 31054894.
37. Richardson AI, Yin CC, Cui W, Li N, Medeiros LJ, Li L, Zhang D. p53 and β-Catenin Expression Predict Poorer Prognosis in Patients With Anaplastic Large-Cell Lymphoma. Clin Lymphoma Myeloma Leuk 19(7):e385-e392, 2019. e-Pub 2019. PMID: 31078446.
38. Quesada AE, Routbort MJ, DiNardo CD, Bueso-Ramos CE, Kanagal-Shamanna R, Khoury JD, Thakral B, Zuo Z, Yin CC, Loghavi S, Ok CY, Wang SA, Tang Z, Bannon SA, Benton CB, Garcia-Manero G, Kantarjian H, Luthra R, Medeiros LJ, Patel KP. DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high-risk disease. Am J Hematol 94(7):757-766, 2019. e-Pub 2019. PMID: 30963592.
39. Hu B, Patel KP, Chen HC, Wang X, Wang F, Luthra R, Routbort MJ, Kanagal-Shamanna R, Medeiros LJ, Yin CC, Zuo Z, Ok CY, Loghavi S, Tang G, Tambaro FP, Thompson P, Burger J, Jain N, Ferrajoli A, Bose P, Estrov Z, Keating MJ, Wierda WG. Routine sequencing in CLL has prognostic implications and provides new insight into pathogenesis and targeted treatments. Br J Haematol 185(5):852-864, 2019. e-Pub 2019. PMID: 30924136.
40. Xie W, Wang SA, Yin CC, Xu J, Li S, Bueso-Ramos CE, Medeiros LJ, Tang G. Acute myeloid leukemia with t(8;21)(q22;q22.1)/RUNX1-RUNX1T1 and KIT Exon 8 mutation is associated with characteristic mastocytosis and dismal outcomes. Exp Mol Pathol 108:131-136, 2019. e-Pub 2019. PMID: 31004601.
41. Veletic I, Manshouri T, Multani AS, Yin CC, Chen L, Verstovsek S, Estrov Z. Myelofibrosis osteoclasts are clonal and functionally impaired (Imaged selected as the cover page by the journal). Blood 133(21):2320-2324, 2019. e-Pub 2019. PMID: 30745304.
42. Xu J, Wang L, Li J, Saksena A, Wang SA, Shen J, Hu Z, Lin P, Tang G, Yin CC, Wang M, Medeiros LJ, Li S. SOX11-Negative Mantle Cell Lymphoma: Clinicopathologic and Prognostic Features of 75 Patients. Am J Surg Pathol 43(5):710-716, 2019. PMID: 30768440.
43. Aung PP, Sukswai N, Nejati R, Loghavi S, Chen W, Torres-Cabala CA, Yin CC, Konopleva M, Zheng X, Wang J, Tang Z, Medeiros LJ, Prieto VG, Pemmaraju N, Khoury JD. PD1/PD-L1 Expression in Blastic Plasmacytoid Dendritic Cell Neoplasm. Cancers (Basel) 11(5), 2019. e-Pub 2019. PMID: 31109153.
44. Tang Z, Tang G, Hu S, Patel KP, Yin CC, Wang W, Lin P, Toruner GA, Ok CY, Gu J, Lu X, Khoury JD, Medeiros LJ. Deciphering the complexities of MECOM rearrangement-driven chromosomal aberrations. Cancer Genet 233-234:21-31, 2019. e-Pub 2019. PMID: 31109591.
45. Hu Z, Ramos CEB, Medeiros LJ, Zhao C, Yin CC, Li S, Hu S, Wang W, Thakral B, Xu J, Verstovsek S, Lin P. Utility of JAK2 V617F Allelic Burden in Distinguishing Chronic Myelomonocytic Leukemia From Primary Myelofibrosis with Monocytosis. Hum Pathol 85:290-298, 2019. e-Pub 2018. PMID: 30447300.
46. Li N, Wang SA, Lin P, Jabbour E, Thompson P, Chen Z, Li S, Xu J, You MJ, Bueso-Ramos CE, Medeiros LJ, Yin CC. Relapsed B-Acute Lymphoblastic Leukemia with Aberrant Myeloperoxidase Expression Following CAR T-cell Therapy: A Diagnostic Challenge. Am J Hematol. e-Pub 2019. PMID: 30916805.
47. Ok CY, Loghavi S, Sui D, Wei P, Kanagal-Shamanna R, Yin CC, Zuo Z, Routbort MJ, Tang G, Tang Z, Jorgensen JL, Luthra R, Ravandi F, Kantarjian HM, DiNardo CD, Medeiros LJ, Wang SA, Patel KP. Persistent IDH1/2 mutation in remission can predict relapse in patients with acute myeloid leukemia. Haematologica 104(2):305-311, 2019. e-Pub 2018. PMID: 30171025.
48. Garces S, Yin CC, Patel KP, Khoury JD, Manning JT, Li S, Xu J, Pina-Oviedo S, Johnson MR, González S, Molgó M, Ruiz-Cordero R, Medeiros LJ. Focal Rosai-Dorfman disease coexisting with lymphoma in the same anatomic site: a localized histiocytic proliferation associated with MAPK/ERK pathway activation. Mod Pathol 32(1):16-26, 2019. e-Pub 2018. PMID: 30323237.
49. Patel KP, Ruiz-Cordero R, Chen W, Routbort MJ, Floyd K, Rodriguez S, Galbincea J, Barkoh BA, Hatfield D, Khogeer H, Kanagal-Shamanna R, Yin CC, Zuo Z, Loghavi S, Ok CY, DiNardo CD, Luthra R, Medeiros LJ. Ultra-Rapid Reporting of GENomic Targets (URGENTseq): Clinical Next-Generation Sequencing Results within 48 Hours of Sample Collection. J Mol Diagn 21(1):89-98, 2019. PMID: 30577887.
50. Hidalgo-Lopez JE, Kanagal-Shamanna R, Quesada AE, Gong Z, Wang W, Hu S, Medeiros LJ, Bassett RL, d'Orcy E, Yin CC, Cortes J, Jabbour EJ, Kantarjian HM, Bueso-Ramos CE. Bone marrow core biopsy in 508 consecutive patients with chronic myeloid leukemia: Assessment of potential value. Cancer 124(19):3849-3855, 2018. e-Pub 2018. PMID: 30321462.
51. Tang Z, Li Y, Wang W, Yin CC, Tang G, Aung PP, Hu S, Lu X, Toruner GA, Medeiros LJ, Khoury JD. Genomic aberrations involving 12p/ETV6 are highly prevalent in blastic plasmacytoid dendritic cell neoplasms and might represent early clonal events. Leuk Res 73:86-94, 2018. e-Pub 2018. PMID: 30248580.
52. Liu H, Wang SA, Schlette EJ, Xu J, Jorgensen JL, Yin CC, Li S, Medeiros LJ, Tang G. Myeloid neoplasms with t(16;21)(q24;q22)/RUNX1-RUNX1T3 mimics acute myeloid leukemia with RUNX1-RUNX1T1. Ann Hematol 97(10):1775-1783, 2018. e-Pub 2018. PMID: 29872884.
53. Huang W, Medeiros LJ, Lin P, Wang W, Tang G, Khoury J, Konoplev S, Yin CC, Xu J, Oki Y, Li S. MYC/BCL2/BCL6 Triple Hit Lymphoma: A Study of 40 Patients with a Comparison to MYC/BCL2 and MYC/BCL6 Double Hit Lymphomas. Mod Pathol 31(9):1470-1478, 2018. e-Pub 2018. PMID: 29785017.
54. Verstovsek S, Subbiah V, Masarova L, Yin CC, Tang G, Manshouri T, Asatiani E, Daver NG. Treatment of the myeloid/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 inhibitor. Ann Oncol 29(8):1880-1882, 2018. PMID: 29767670.
55. Jabbar KJ, Yin CC, Bueso-Ramos CE, Luthra R, Medeiros LJ, Zuo Z. Higher body mass index is associated with better survival in patients with myelodysplastic syndromes. Leuk Res 71:63-66, 2018. e-Pub 2018. PMID: 30015105.
56. Kurt H, Jorgensen JL, Amin HM, Patel KP, Wang SA, Lin P, Kanagal-Shamanna R, Loghavi S, Thakral B, Khogeer HA, Jabbour EJ, Li S, Yin CC, Medeiros LJ, Khoury JD. Chronic lymphoproliferative disorder of NK cells: a single-institution review with emphasis on relative utility of multimodality diagnostic tools. Eur J Haematol 100(5):444-454, 2018. e-Pub 2018. PMID: 29385279.
57. Hidalgo López JE, Carballo-Zarate A, Verstovsek S, Wang SA, Hu S, Li S, Xu J, Zuo W, Tang Z, Yin CC, Medeiros LJ, Bueso-Ramos CE, Tang G. Bone marrow findings in blast phase of polycythemia vera. Ann Hematol 97(3):425-434, 2018. e-Pub 2017. PMID: 29285580.
58. Xu J, Medeiros LJ, Saksena A, Wang M, Zhou J, Li J, Yin CC, Tang G, Wang L, Lin P, Li S. CD10-positive mantle cell lymphoma: clinicopathologic and prognostic study of 30 cases. Oncotarget 9(14):11441-11450, 2018. e-Pub 2017. PMID: 29545910.
59. Hu Z, Sun Y, Schlette EJ, Tang G, Li S, Xu J, Yin CC, Young KH, Patel KP, Miranda RN, Goswami M, Wang M, Jorgensen JL, Medeiros LJ, Wang SA. CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course. Mod Pathol 31(2):327-336, 2018. e-Pub 2017. PMID: 28984300.
60. Quesada AE, Hu Z, Routbort MJ, Patel KP, Luthra R, Loghavi S, Zuo Z, Yin CC, Kanagal-Shamanna R, Wang SA, Jorgensen JL, Medeiros LJ, Ok CY. Mixed phenotype acute leukemia contains heterogeneous genetic mutations by next-generation sequencing. Oncotarget 9(9):8441-8449, 2018. e-Pub 2018. PMID: 29492206.
61. Li J, Xu J, Abruzzo LV, Tang G, Li S, You MJ, Lu G, Jabbour EJ, Deng Q, Bueso-Ramos CE, Medeiros LJ, Yin CC. Acute myeloid leukemia with t(4;12)(q12;p13): An aggressive disease with frequent involvement of PDGFRA and ETV6. Oncotarget 9(13):10987-10994, 2018. e-Pub 2017. PMID: 29541391.
62. Ng SB, Chung TH, Kato S, Nakamura S, Takahashi E, Ko YH, Khoury JD, Yin CC, Soong R, Jeyasekharan AD, Hoppe MM, Selvarajan V, Tan SY, Lim ST, Ong CK, Nairismägi ML, Maheshwari P, Choo SN, Fan S, Lee CK, Chuang SS, Chng WJ. Epstein-Barr virus-associated primary nodal T/NK-cell lymphoma shows a distinct molecular signature and copy number changes. Haematologica 103(2):278-287, 2018. e-Pub 2017. PMID: 29097495.
63. Quesada AE, Medeiros LJ, Desai PA, Lin P, Westin JR, Hawsawi HM, Wei P, Tang G, Seegmiller AC, Reddy NM, Yin CC, Wang W, Xu J, Miranda RN, Zuo Z, Li S. Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma. Mod Pathol 30(12):1688-1697, 2017. e-Pub 2017. PMID: 28776574.
64. Zhang H, Li L, Wang Y, Yin CC, Xie Y, Liu X, Ding H, Tian Z, Shen J, He L, Xia M, Ma X, Wu L. Functional analysis of BRCT missense mutations in BRCA1-mutated Chinese Han familial breast cancer. Oncol Lett 14(5):5839-5844, 2017. e-Pub 2017. PMID: 29113215.
65. Xue Y, Han H, Wu L, Pan B, Dong B, Yin CC, Tian Z, Liu X, Yang Y, Zhang H, Chen Y, Chen J. iASPP facilitates tumor growth by promoting mTOR-dependent autophagy in human non-small cell lung cancer. Cell Death Dis 8(10):e3150, 2017. e-Pub 2017. PMID: 29072696.
66. Garces S, Medeiros LJ, Patel KP, Li S, Pina-Oviedo S, Li J, Garces JC, Khoury JD, Yin CC. Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease. Mod Pathol 30(10):1367-1377, 2017. e-Pub 2017. PMID: 28664935.
67. Jain P, Kantarjian H, Jain N, Short NJ, Yin CC, Kanagal-Shamanna R, Khoury J, Konopleva M, Sasaki K, Kadia TM, Garris R, Pierce S, Estrov Z, Wierda W, Cortes J, O'Brien S, Ravandi F, Jabbour E. Clinical characteristics and outcomes of previously untreated patients with adult onset T-ALL and T-lymphoblastic lymphoma (T-LL) with hyper-CVAD based regimens. Am J Hematol 92(10):E595-E597, 2017. e-Pub 2017. PMID: 28646517.
68. Kanagal-Shamanna R, Jain P, Takahashi K, Short NJ, Tang G, Issa GC, Ravandi F, Garcia-Manero G, Yin CC, Luthra R, Patel KP, Khoury JD, Montalban-Bravo G, Sasaki K, Kadia TM, Borthakur G, Konopleva M, Jain N, Garris R, Pierce S, Wierda W, Estrov Z, Cortes J, O'Brien S, Kantarjian HM, Jabbour E. TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper-CVAD-based regimens. Cancer 123(19):3717-3724, 2017. e-Pub 2017. PMID: 28608976.
69. Tang G, Hidalgo Lopez JE, Wang SA, Hu S, Ma J, Pierce S, Zuo W, Carballo-Zarate AA, Yin CC, Tang Z, Li S, Medeiros LJ, Verstovsek S, Bueso-Ramos CE. Characteristics and clinical significance of cytogenetic abnormalities in polycythemia vera. Haematologica 102(9):1511-1518, 2017. e-Pub 2017. PMID: 28473622.
70. Hidalgo-López JE, Kanagal-Shamanna R, Medeiros LJ, Estrov Z, Yin CC, Verstovsek S, Konoplev S, Jorgensen JL, Mohammad MM, Miranda RN, Zhao C, Lee J, Zuo Z, Bueso-Ramos CE. Morphologic and molecular characteristics of de novo AML with JAK2 V617F mutation. J Natl Compr Canc Netw 15(6):790-796, 2017. PMID: 28596259.
71. Khan M, Yin CC, Yates A, Newberry KJ, Verstovsek S. A rare case of primary myelofibrosis in a 14-year-old patient with congenital asplenia. J Pediatr Hematol Oncol 39(4):e196-e198, 2017. PMID: 27403772.
72. Pina-Oviedo S, Medeiros LJ, Li S, Khoury JD, Patel KP, Alayed K, Cason RC, Bowman CJ, Yin CC. Langerhans cell histiocytosis associated with lymphoma: an incidental finding that is not associated with BRAF or MAP2K1 mutations. Mod Pathol 30(5):734-744, 2017. e-Pub 2017. PMID: 28084334.
73. Abaza Y, Yin CC, Bueso-Ramos CE, Wang SA, Verstovsek S. Primary autoimmune myelofibrosis: a case report and review of the literature. Int J Hematol 105(4):536-539, 2017. e-Pub 2016. PMID: 27830539.
74. Thakral B, Medeiros LJ, Desai P, Lin P, Yin CC, Tang G, Khoury JD, Hu S, Xu J, Loghavi S, Hu B, Oki Y, Li S. Prognostic impact of CD5 expression in diffuse large B-cell lymphoma in patients treated with rituximab-EPOCH. Eur J Haematol 98(4):415-421, 2017. e-Pub 2017. PMID: 28039906.
75. Short NJ, Kantarjian HM, Sasaki K, Ravandi F, Ko H, Yin CC, Garcia-Manero G, Cortes JE, Garris R, O'Brien SM, Patel K, Khouri M, Thomas D, Jain N, Kadia TM, Daver NG, Benton CB, Issa GC, Konopleva M, Jabbour E. Poor outcomes associated with +der(22)t(9;22) and -9/9p in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving chemotherapy plus a tyrosine kinase inhibitor. Am J Hematol 92(3):238-243, 2017. e-Pub 2017. PMID: 28006851.
76. Jain P, Wang SA, Yin CC, Abaza Y, Verstovsek S, Estrov Z. A case of lymphocytic variant hypereosinophilic syndrome with sub-diagnostic systemic mastocytosis. Blood Res 52(1):71-73, 2017. e-Pub 2017. PMID: 28401108.
77. Xu J, Oki Y, Saksena A, Desai P, Lin P, Tang G, Yin CC, You MJ, Thakral B, Medeiros LJ, Li S. CD30 expression and prognostic significance in R-EPOCH treated patients with diffuse large B-cell lymphoma. Hum Pathol 60:160-166, 2017. e-Pub 2016. PMID: 27816715.
78. Issa GC, Kantarjian HM, Yin CC, Qiao W, Ravandi F, Thomas D, Short NJ, Sasaki K, Garcia-Manero G, Kadia TM, Cortes JE, Daver N, Borthakur G, Jain N, Konopleva M, Khouri I, Kebriaei P, Champlin RE, Pierce S, O'Brien SM, Jabbour E. Prognostic impact of pretreatment cytogenetics in adult Philadelphia chromosome-negative acute lymphoblastic leukemia in the era of minimal residual disease. Cancer 123(3):459-467, 2017. e-Pub 2016. PMID: 27696391.
79. Boddu P, Yin CC, Kanagal-Shamanna R, Tang G, Thakral B, Kadia T, Konopleva M, Jabbour E, Jain N. An unusual finding of t (9;22): a rare case of Philadelphia chromosome-positive B-lymphoblastic lymphoma. Case Rep Hematol 2017:2413587, 2017. e-Pub 2017. PMID: 29075538.
80. Masarova L, Yin CC, Cortes JE, Konopleva M, Borthakur G, Newberry KJ, Kantarjian HM, Bueso-Ramos CE, Verstovsek S. Histomorphological responses after therapy with pegylated interferon α-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV). Exp Hematol Oncol 6:30, 2017. e-Pub 2017. PMID: 29152412.
81. Wang W, Chen Z, Hu Z, Yin CC, Li S, Bai S, Bueso-Ramos CE, Medeiros LJ, Hu S. Clinical significance of trisomy 8 that emerges during therapy in chronic myeloid leukemia. Blood Cancer J 6(11):e490, 2016. e-Pub 2016. PMID: 27813536.
82. Hidalgo Lopez JE, Yabe M, Carballo-Zarate AA, Wang SA, Jorgensen JL, Ahmed S, Lee J, Li S, Schlette E, McDonnell T, Miranda RN, Medeiros LJ, Bueso-Ramos CE, Yin CC. Donor-derived T-cell large granular lymphocytic leukemia in a patient with peripheral T-cell lymphoma. J Natl Compr Canc Netw 14(8):939-44, 2016. PMID: 27496109.
83. Chen Z, Cortes JE, Jorgensen JL, Wang W, Yin CC, You MJ, Jabbour E, Kantarjian HM, Medeiros LJ, Hu S. Differential impact of additional chromosomal abnormalities in myeloid vs lymphoid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy. Leukemia 30(7):1606-9, 2016. e-Pub 2016. PMID: 26837843.
84. Alayed K, Medeiros LJ, Patel KP, Zuo Z, Li S, Verma S, Galbincea J, Cason RC, Luthra R, Yin CC. BRAF and MAP2K1 mutations in Langerhans cell histiocytosis: a study of 50 cases. Hum Pathol 52:61-7, 2016. e-Pub 2016. PMID: 26980021.
85. Li S, Saksena A, Desai P, Xu J, Zuo Z, Lin P, Tang G, Yin CC, Seegmiller A, Jorgensen JL, Miranda RN, Reddy NM, Bueso-Ramos C, Medeiros LJ. Prognostic impact of history of follicular lymphoma, induction regimen and stem cell transplant in patients with MYC/BCL2 double hit lymphoma. Oncotarget 7(25):38122-38132, 2016. e-Pub 2016. PMID: 27203548.
86. Jain P, Tang G, Huh YO, Yin CC, Zuo Z, Pemmaraju N, Estrov Z, Daver N. Philadelphia-positive dimorphic blasts in mixed-phenotype acute leukemia with TET2 mutation. Am J Hematol 91(6):647-8, 2016. e-Pub 2016. PMID: 26799924.
87. Hong M, Hao S, Patel KP, Kantarjian HM, Garcia-Manero G, Yin CC, Medeiros LJ, Lin P, Lu X. Whole-arm translocation of der(5;17)(p10;q10) with concurrent TP53 mutations in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): a unique molecular-cytogenetic subgroup. Cancer Genet 209(5):205-14, 2016. e-Pub 2016. PMID: 27134073.
88. Aung FM, Lichtiger B, Rondon G, Yin CC, Alousi A, Ahmed S, Andersson BS, Bashir Q, Ciurea SO, Hosing C, Jones R, Kebriaei P, Khouri I, Nieto Y, Oran B, Parmar S, Qazilbash M, Shah N, Shpall EJ, Champlin RE, Popat U. Pure Red Cell Aplasia in Major ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Severe Pancytopenia. Biol Blood Marrow Transplant 22(5):961-5, 2016. e-Pub 2016. PMID: 26921820.
89. Aye le L, Loghavi S, Young KH, Siddiqi I, Yin CC, Routbort MJ, Liang M, Eilerman K, Medeiros LJ, Brynes RK, Bueso-Ramos C. Preleukemic phase of chronic myelogenous leukemia: morphologic and immunohistochemical characterization of 7 cases. Ann Diagn Pathol 21:53-8, 2016. e-Pub 2016. PMID: 27040932.
90. Kanagal-Shamanna R, Luthra R, Yin CC, Patel KP, Takahashi K, Lu X, Lee J, Zhao C, Stingo F, Zuo Z, Routbort MJ, Singh RR, Fox P, Ravandi F, Garcia-Manero G, Medeiros LJ, Bueso-Ramos CE. Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRAS. Oncotarget 7(12):14251-8, 2016. PMID: 26883102.
91. Li S, Desai P, Lin P, Yin CC, Tang G, Wang XJ, Konoplev SN, Khoury JD, Bueso-Ramos CE, Medeiros LJ. MYC/BCL6 double hit lymphoma (DHL): A tumor associated with an aggressive clinical course and poor prognosis. Histopathology 68(7):1090-8, 2016. PMID: 26426741.
92. Liu J, Xia M, Wang P, Wang C, Geng Z, Yin CC, Qiu X. Immunoglobulin gene expression in umbilical cord blood-derived CD34+ hematopoietic stem/progenitor cells. Gene 575:108-17, 2016.
93. Wu L, Yao L, Zhang H, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Yin CC, Xie Y. A genome-wide association study identifies WT1 variant with better response to 5-fluorouracil, pirarubicin, and cyclophosphamide neoadjuvant chemotherapy in breast cancer patients. Oncotarget 7(4):5042-52, 2016. PMID: 26573232.
94. Li S, Weiss VL, Wang XJ, Desai PA, Hu S, Yin CC, Tang G, Reddy NM, Medeiros LJ, Lin P. High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis. Am J Surg Pathol 40(2):253-61, 2016. PMID: 26448193.
95. Tang Z, Medeiros LJ, Yin CC, Wang W, Lu X, Young KH, Khoury JD, Tang G. Sex chromosome loss after allogeneic hematopoietic stem cell transplant in patients with hematologic neoplasms: A diagnostic dilemma for clinical cytogeneticists. Mol Cytogenet 9:62-68, 2016. e-Pub 2016. PMID: 27508005.
96. Wang C, Xia M, Sun X, He Z, Hu F, Chen L, Bueso-Ramos CE, Qiu X, Yin CC. IGK with conserved IG?V/IG?J repertoire is expressed in acute myeloid leukemia and promotes leukemic cell migration. Oncotarget 6(36):39062-72, 2015. PMID: 26429876.
97. Loghavi S, Al-Ibraheemi A, Zuo Z, Garcia-Manero G, Yabe M, Wang SA, Kantarjian HM, Yin CC, Miranda RN, Luthra R, Medeiros LJ, Bueso-Ramos CE, Khoury JD. TP53 overexpression is an independent adverse prognostic factor in de novo myelodysplastic syndromes with fibrosis. Br J Haematol 171(1):91-9, 2015. e-Pub 2015. PMID: 26123119.
98. Chakhachiro Z, Yin CC, Abruzzo LV, Aladily TN, Barron LL, Banks HE, Thomas DA, Keating M, Medeiros LJ, Huh YO. B-lymphoblastic leukemia in patients with chronic lymphocytic leukemia: a report of four cases. Am J Clin Pathol 144(2):333-40, 2015. PMID: 26185320.
99. Yin CC, Peng J, Li Y, Shamanna RK, Muzzafar T, DiNardo C, Khoury JD, Li S, Medeiros LJ, Wang SA, Tang G. Clinical significance of newly emerged isolated del(20q) in patients following cytotoxic therapies. Mod Pathol 28(8):1014-22, 2015. e-Pub 2015. PMID: 26044451.
100. Loghavi S, Alayed K, Aladily TN, Zuo Z, Ng SB, Tang G, Hu S, Yin CC, Miranda RN, Medeiros LJ, Khoury JD. Stage, age and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients. J Hematol Oncol 10(8):65-75, 2015. e-Pub 2015. PMID: 26055271.
101. Cao X, Ye Q, Orlowski RZ, Wang X, Loghavi S, Tu M, Thomas SK, Shan J, Li S, Qazilbash M, Yin CC, Weber D, Miranda RN, Xu-Monette ZY, Medeiros LJ, Young KH. Waldenström macroglobulinemia with extramedullary involvement at initial diagnosis portends a poorer prognosis. J Hematol Oncol 8:74, 2015. e-Pub 2015. PMID: 26104577.
102. Wang XI, Yin CC, Qazilbash MH, Hu S, Lu G. Clinical Significance of Acquired Cytogenetic Clones in Patients With Treated Follicular Lymphoma. Clin Lymphoma Myeloma Leuk 15(5):262-9, 2015. e-Pub 2014. PMID: 25573378.
103. Li Y, Hu S, Zuo Z, Hong M, Lin P, Li S, Konoplev S, Wang Z, Khoury JD, Young KH, Medeiros LJ, Yin CC. CD5-positive follicular lymphoma: clinicopathologic correlations and outcome in 88 cases. Mod Pathol 28(6):787-98. e-Pub 2015. PMID: 25743023.
104. Liao Q, Liu W, Liu Y, Wang F, Wang C, Zhang J, Chu M, Jiang D, Xiao L, Shao W, Sheng Z, Tao X, Huo L, Yin CC, Zhang Y, Lee G, Huang J, Li Z, Qiu X. Aberrant high expression of immunoglobulin G in epithelial stem/progenitor-like cells contributes to tumor initiation and metastasis. Oncotarget 6(37):40081-94, 2015. e-Pub 2015. PMID: 26472025.
105. Yin CC, Jain N, Mehrotra M, Zhang J, Protopopov A, Zuo Z, Pemmaraju N, DiNardo C, Hirsch-Ginsberg C, Wang SA, Medeiros LJ, Chin L, Patel KP, Ravandi F, Futreal A, Bueso-Ramos CE. Identification of a novel fusion gene, IRF2BP2-RARA, in acute promyelocytic leukemia. J Natl Compr Canc Netw 13(1):19-22, 2015. PMID: 25583766.
106. Yin CC, Tang G, Lu G, Feng X, Keating MJ, Medeiros LJ, Abruzzo LV. Del(20q) in patients with chronic lymphocytic leukemia: a therapy-related abnormality involving lymphoid or myeloid cells (received Ten Best Pathology Papers award by MKLinx Pathology). Mod Pathol 28(8):1130-7, 2015. e-Pub 2015. PMID: 25953391.
107. Goswami RS, Liang CS, Bueso-Ramos CE, Hu S, Goswami M, Yin CC, Lu G, Medeiros LJ, Tang G. Isolated +15 in bone marrow: Disease-associated or a benign finding?. Leuk Res 39(1):72-6, 2015. e-Pub 2014. PMID: 25435027.
108. Liu H, Wang W, Tang G, Yin CC, Muzzafar T, Medeiros LJ, Hu S. Lymphomatous variant of hairy cell leukemia: a distinctive presentation mimicking low-grade B-cell lymphoma. Histopathology 67(5):740-5, 2015. PMID: 25809821.
109. Wang XJ, Medeiros LJ, Lin P, Yin CC, Hu S, Thompson MA, Li S. MYC Cytogenetic Status Correlates With Expression and Has Prognostic Significance in Patients With MYC/BCL2 Protein Double-positive Diffuse Large B-cell Lymphoma. Am J Surg Pathol 39(9):1250-8, 2015. e-Pub 2015. PMID: 25828389.
110. Wang W, Tang G, Cortes JE, Liu H, Ai D, Yin CC, Li S, Khoury JD, Bueso-Ramos C, Medeiros LJ, Hu S. Chromosomal rearrangement involving 11q23 locus in chronic myelogenous leukemia: a rare phenomenon frequently associated with disease progression and poor prognosis. J Hematol Oncol 8(1):32-8, 2015. e-Pub 2015. PMID: 25888368.
111. Liu Y, Liu D, Wang C, Liao Q, Huang J, Jiang D, Shao W, Yin CC, Zhang Y, Lee G, Qiu X. Binding of the mAb RP215 to IgG in metastatic lung adenocarcinomas is correlated with poor prognosis. Histopathology 67(5):645-53, 2015. e-Pub 2015. PMID: 25753759.
112. Jabbour E, Kantarjian H, Ravandi F, Thomas D, Huang X, Faderl S, Pemmaraju N, Daver N, Garcia-Manero G, Sasaki K, Cortes J, Garris R, Yin CC, Khoury JD, Jorgensen J, Estrov Z, Bohannan Z, Konopleva M, Kadia T, Jain N, DiNardo C, Wierda W, Jeanis V, O'Brien S. Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study. Lancet Oncol 16(15):1547-55, 2015. PMID: 26432046.
113. Ma H, Mallampati S, Lu Y, Sun B, Wang E, Leng X, Gong Y, Shen H, Yin CC, Jones D, Amin HM, You MJ, Zweidler-McKay P, Ma Y, Kantarjian HM, Arlinghaus RB, Glassman A, Sun X. Sox4/Tcf7l1 axis promotes progression of BCR-ABL+ acute lymphoblastic leukemia. Haematologica 99(10):1591-8, 2014. e-Pub 2014. PMID: 24997151.
114. Rich A, Sun J, Aldayel AS, Yin CC, Medeiros LJ, Konoplev S. Myelomastocytic Leukemia With Aberrant CD25 Expression: Case Report and Review of the Literature. Clin Lymphoma Myeloma Leuk 14(5):e173-7, 2014. e-Pub 2014. PMID: 25022599.
115. Wang S, Medeiros LJ, Xu-Monette ZY, Zhang S, O'Malley DP, Orazi A, Zuo Z, Bueso-Ramos CE, Yin CC, Liu Z, Miranda RN, Young KH. Epstein-Barr virus-positive nodular lymphocyte predominant Hodgkin lymphoma. Ann Diagn Pathol 18(4):203-9, 2014. e-Pub 2014. PMID: 24852241.
116. Tang G, Wang SA, Lu V, Lee HC, Qazilbash MH, Wang XI, Yin CC, Orlowski R, Wang Y, Patel A, Medeiros LJ, Lu G. Clinically silent clonal cytogenetic abnormalities arising in patients treated for lymphoid neoplasms. Leuk Res 38(8):896-900, 2014. e-Pub 2014. PMID: 24939217.
117. Dai CW, Bai QW, Zhang GS, Cao YX, Shen JK, Pei MF, Yin CC. MicroRNA let-7f is down-regulated in patients with refractory acute myeloid leukemia and is involved in chemotherapy resistance of adriamycin-resistant leukemic cells. Leuk Lymphoma 55(7):1645-8, 2014. e-Pub 2013. PMID: 24067109.
118. Ok CY, Yin CC, Yabe M, Bueso-Ramos CE, Miranda RN, Medeiros LJ, Konoplev SN. Lymphoma with Features Intermediate Between Aggressive T-Large Granular Lymphocytic Leukemia and Hepatosplenic T-Cell Lymphoma: a Diagnostic Dilemma?. Clin Lymphoma Myeloma Leuk 14(3):e95-100, 2014. e-Pub 2014. PMID: 24524924.
119. DiNardo CD, Daver N, Jain N, Pemmaraju N, Bueso-Ramos C, Yin CC, Pierce S, Jabbour E, Cortes JE, Kantarjian HM, Garcia-Manero G, Verstovsek S. Myelodysplastic/Myeloproliferative neoplasms, unclassifiable (MDS/MPN, U): Natural history and clinical outcome by treatment strategy. Leukemia 28(4):958-61, 2014. e-Pub 2014. PMID: 24492324.
120. Jaso JM, Yin CC, Lu VW, Zhao M, Abruzzo LV, You MJ, Yang Y, Luthra R, Medeiros LJ, Lu G. B-acute lymphoblastic leukemia with t(14;19)(q32;p13.1) involving IGH/EPOR: a clinically aggressive subset of disease. Mod Pathol 27(3):382-9, 2014. e-Pub 2013. PMID: 24030742.
121. Huang J, Sun X, Gong X, He Z, Chen L, Qiu X, Yin CC. Rearrangement and expression of the immunoglobulin μ-chain gene in human myeloid cells. Cell Mol Immunol 11(1):94-104, 2014. e-Pub 2013. PMID: 24141767.
122. Wang XI, Lu X, Yin CC, Zhao L, Bueso-Ramos CE, Medeiros LJ, Li S, Rogers J, Hsi ED, Lin P. Myeloid neoplasm associated with t(3;12)(q26.2;p13) are clinically aggressive and frequently harbor FLT3 mutations. J Leukemia 2:161, 2014.
123. Jaso JM, Yin CC, Wang SA, Miranda RN, Jabcuga CE, Chen L, Medeiros LJ. Clinicopathologic features of CD5-positive nodal marginal zone lymphoma. Am J Clin Pathol 140(5):693-700, 2013. PMID: 24124149.
124. Zhou Y, Fan X, Routbort M, Yin CC, Singh R, Bueso-Ramos C, Thomas DA, Milton DR, Medeiros LJ, Lin P. Absence of terminal deoxynucleotidyl transferase expression identifies a subset of high risk adult T-lymphoblastic leukemia/lymphoma. Mod Pathol 26(10):1338-45, 2013. e-Pub 2013. PMID: 23702731.
125. Hu S, Bueso-Ramos CE, Verstovsek S, Miranda RN, Yin CC, McDonnell T, Medeiros LJ, Lin P. Metastatic Splenic Angiosarcoma Presenting With Thrombocytopenia and Bone Marrow Fibrosis Mimicking Idiopathic Thrombocytopenic Purpura and Primary Myelofibrosis: A Diagnostic Challenge. Clin Lymphoma Myeloma Leuk 13(5):629-33, 2013. e-Pub 2013. PMID: 23800601.
126. Benjamini O, Jain P, Konoplev SN, Yin CC, Abruzzo L, Wotherspoon AC, Dearden C, Shpall EJ, Estrov Z, Keating MJ. CD4(-)/CD8(-) Variant of T-Cell Large Granular Lymphocytic Leukemia or Hepatosplenic T-Cell Lymphoma: A Clinicopathologic Dilemma. Clin Lymphoma Myeloma Leuk 13(5):610-3, 2013. e-Pub 2013. PMID: 23800602.
127. Li S, Lin P, Young KH, Kanagal-Shamanna R, Yin CC, Medeiros LJ. MYC/BCL2 double-hit high-grade B-cell lymphoma. Adv Anat Pathol 20(5):315-26, 2013. PMID: 23939148.
128. Lu G, Schulz RA, Bueso-Ramos CE, Cortes JE, Iris Wang X, Medeiros LJ, Yin CC. Double-hit of FLT3 gene in a fatal case of acute myemonocytic leukaemia. J Clin Pathol 66(9):826-9, 2013. e-Pub 2013. PMID: 23703854.
129. Li S, Feng X, Li T, Zhang S, Zuo Z, Lin P, Konoplev S, Bueso-Ramos CE, Vega F, Medeiros LJ, Yin CC. Extranodal NK/T-Cell lymphoma, nasal type: A report of 73 cases at MD Anderson Cancer Center. Am J Surg Pathol 37(1):14-23, 2013. PMID: 23232851.
130. Hoehn D, Lu G, Konoplev S, Zhou Y, Bueso-Ramos CE, Zuo Z, Hsu B, Medeiros LJ, Yin CC. t(15;17)(q24.1;q21.2)/PML-RARA in blast phase of chronic myelogenous leukemia: a rare form of clonal evolution. J Hematopathol 6(4):187-93, 2013.
131. Konoplev S, Yin CC, Kornblau SM, Kantarjian HM, Konopleva M, Andreeff M, Lu G, Zuo Z, Luthra R, Medeiros LJ, Bueso-Ramos CE. Molecular characterization of de novo Philadelphia chromosome-positive acute myeloid leukemia. Leuk Lymphoma 54(1):138-44, 2013. e-Pub 2012. PMID: 22691121.
132. Qiu X, Sun X, He Z, Huang J, Hu F, Chen L, Lin P, You MJ, Medeiros LJ, Yin CC. Immunoglobulin gamma heavy chain gene with somatic hypermutation is frequently expressed in acute myeloid leukemia (Received one of the 20 Diploma of Excellence Awards by Leukemia). Leukemia 27(1):92-9, 2013. e-Pub 2012. PMID: 22772058.
133. Kanagal-Shamanna R, Yin CC, Miranda RN, Bueso-Ramos CE, Wang XI, Muddasani R, Medeiros LJ, Lu G. Therapy-related myeloid neoplasms with isolated del(20q): comparison with cases of de novo myelodysplastic syndrome with del(20q). Cancer Genet 206(1-2):42-6, 2013. e-Pub 2013. PMID: 23357231.
134. Konoplev S, Lin P, Yin CC, Lin E, Nogueras González GM, Kantarjian HM, Andreeff M, Medeiros LJ, Konopleva M. CXC Chemokine Receptor 4 Expression, CXC Chemokine Receptor 4 Activation, and Wild-Type Nucleophosmin Are Independently Associated With Unfavorable Prognosis in Patients With Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk 13(6):686-92, 2013. e-Pub 2013. PMID: 24035716.
135. Jabbour E, Morris V, Kantarjian H, Yin CC, Burton E, Cortes J. Characteristics and outcomes of patients with V299L BCR-ABL kinase domain mutation after therapy with tyrosine kinase inhibitors. Blood 120(16):3382-3, 2012. PMID: 23086624.
136. Li S, Yin CC, Medeiros LJ, Bueso-Ramos C, Lu G, Lin P. Myelodysplastic syndrome/acute myeloid leukemia with t(3;21)(q26.2;q22) is commonly a therapy-related disease associated with poor outcome. Am J Clin Pathol 138(1):146-52, 2012. PMID: 22706870.
137. Li S, Lin P, Fayad LE, Lennon PA, Miranda RN, Yin CC, Lin E, Medeiros LJ. B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome. Mod Pathol 25(1):145-56, 2012. e-Pub 2011. PMID: 22002575.
138. Hoehn D, Yin CC, Chen L, Sheridan G, Wenig BM. Diagnosing hypocellular collagenized spindle cell squamous carcinoma of the head and neck: A rare subtype with misleading histologic features. N Am J Med Sci 5(1):9-12, 2012.
139. Jaso J, Chen L, Li S, Lin P, Chen W, Miranda RN, Konoplev S, Medeiros LJ, Yin CC. CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma: a clinicopathologic study of 14 cases. Hum Pathol 43(9):1436-43, 2012. PMID: 22406370.
140. Bai B, Zuo Z, Cheong SH, Vo B, Harper E, Lovshe D, Yang S, Yin CC. Novel chromosomal aberration as evidence of clonal evolution in a case of relapsed acute myeloid leukemia. N Am J Med Sci 5(1):48-50, 2012.
141. Warren M, Luthra R, Yin CC, Ravandi F, Cortes JE, Kantarjian HM, Medeiros LJ, Zuo Z. Clinical impact of change of FLT3 mutation status in acute myeloid leukemia patients. Mod Pathol 25(10):1405-12, 2012. e-Pub 2012. PMID: 22684224.
142. Ohanian M, Leventaki V, Verstovsek S, Estrov Z, Lin P, Yin CC, Kantarjian H, Huh Y, Ravandi F. Acute lymphoblastic leukemia arising in post-polycythemic myelofibrosis: a rare entity. Leuk Lymphoma 53(9):1839-41, 2012. e-Pub 2012. PMID: 22303899.
143. Hoehn D, Yin CC. Unusual presentation of a dysembryoplastic neuroepithelial tumor mimicking a pontomesencephalic cavernous hemangioma. J Med Cases 3(6):375-8, 2012.
144. Bai B, Lu G, Yin CC. t(1;3)(p36;p21) as the sole clonal abnormality in a case of refractory acute myeloid leukemia. N Am J Med Sci 5(4):235-8, 2012.
145. Aladily TN, Nathwani BN, Miranda RN, Kansal R, Yin CC, Protzel R, Takowsky GS, Medeiros LJ. Extranodal NK/T-cell lymphoma, nasal type arising in association with saline breast implant: expanding the spectrum of breast implant-associated lymphomas. Am J Surg Pathol 36(11):1729-34, 2012. PMID: 23073330.
146. Hu F, Zhang L, Zheng J, Zhao L, Huang J, Shao W, Liao Q, Ma T, Geng L, Yin CC, Qiu X. Spontaneous production of immunoglobulin m in human epithelial cancer cells. PLoS One 7(12):e51423, 2012. e-Pub 2012. PMID: 23251529.
147. Kanagal-Shamanna R, Bueso-Ramos CE, Barkoh B, Lu G, Wang S, Garcia-Manero G, Vadhan-Raj S, Hoehn D, Medeiros LJ, Yin CC. Myeloid neoplasms with isolated isochromosome 17q represent a clinicopathologic entity associated with myelodysplastic/myeloproliferative features, a high risk of leukemic transformation, and wild-type TP53. Cancer 118(11):2879-88, 2012. e-Pub 2011. PMID: 22038701.
148. Sun J, Yin CC, Cui W, Chen SS, Medeiros LJ, Lu G. Chromosome 20q deletion - a recurrent cytogenetic abnormality in patients with chronic myelogenous leukemia in remission. Am J Clin Pathol 135(3):391-7, 2011. PMID: 21350093.
149. Gurevich I, Luthra R, Konoplev SN, Yin CC, Medeiros LJ, Lin P. Refractory anemia with ring sideroblasts associated with marked thrombocytosis: a mixed group exhibiting a spectrum of morphologic findings. Am J Clin Pathol 135(3):398-403, 2011. PMID: 21350094.
150. Barakat FH, Luthra R, Yin CC, Barkoh BA, Hai S, Jamil W, Bhakta YI, Chen S, Medeiros LJ, Zuo Z. Detection of nucleophosmin 1 mutations by quantitative real-time polymerase chain reaction versus capillary electrophoresis: a comparative study. Arch Pathol Lab Med 135(8):994-1000, 2011. PMID: 21809990.
151. Hoehn D, Bala KK, Fan W, Yin CC. Parinaud oculoglandular syndrome as a prominent presenting feature of Kikuchi-Fujimoto disease. N Am J Med Sci 4(2):96-9, 2011.
152. Yin CC, Cortes J, Galbincea J, Reddy N, Breeden M, Jabbour E, Luthra R, Jones D. Rapid clonal shifts in response to kinase inhibitor therapy in chronic myelogenous leukemia are identified by quantitation mutation assays. Cancer Sci 101(9):2005-10, 2010. PMID: 20557306.
153. Zhu X, Wu L, Zhang L, Hao P, Zhang S, Huang J, Zheng J, Liu Y, Li W, Zhang Y, Zhou C, Zhang Y, Yin CC, Qiu X. Distinct regulatory mechanism of immunoglobulin gene transcription in epithelial cancer cells. Cell Mol Immunol 7(4):279-86, 2010. e-Pub 2010. PMID: 20473321.
154. Konoplev S, Lin P, Qiu X, Medeiros LJ, Yin CC. Clonal relationship of extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue involving different sites. Am J Clin Pathol 134(1):112-8, 2010. PMID: 20551275.
155. Talwalkar SS, Yin CC, Naeem RC, Hicks MJ, Strong LC, Abruzzo LV. Myelodysplastic syndromes arising in patients with germline TP53 mutation and Li-Fraumeni syndrome. Arch Pathol Lab Med 134(7):1010-5, 2010. PMID: 20586629.
156. Li T, Medeiros LJ, Lin P, Yin H, Littlejohn M, Im W, Lennon PA, Hu P, Jorgensen JL, Liang M, Guo H, Yin CC. Immunohistochemical profile and fluorescence in situ hybridization analysis of diffuse large B-cell lymphoma in northern China. Arch Pathol Lab Med 134(5):759-65, 2010. PMID: 20441508.
157. Liang M, Han X, Vadhan-Raj S, Nguyen M, Zhang YH, Fernandez M, Drakos E, Konoplev SN, Yin CC, Miranda RN, McDonnell TJ, Medeiros LJ, Bueso-Ramos CE. HDM4 is overexpressed in mantle cell lymphoma and its inhibition induces p21 expression and apoptosis. Mod Pathol 23(3):381-91, 2010. e-Pub 2010. PMID: 20062013.
158. Zhang S, Mao Y, Huang J, Ma T, Zhang L, Zhu X, Zheng J, Wu L, Yin CC, Qiu X. Immunoglobulin gene locus events in epithelial cells of lactating mouse mammary glands. Cell Mol Life Sci 67(6):985-94, 2010. e-Pub 2009. PMID: 20033753.
159. Cui W, Bueso-Ramos CE, Yin CC, Sun J, Chen S, Muddasani R, Lu G. Trisomy 14 as a sole chromosome abnormality is associated with older age, a heterogenous group of myeloid neoplasms with dysplasia and a wide spectrum of disease progression. J Biomed Biotechnol 2010:365318-24, 2010. e-Pub 2011. PMID: 21331167.
160. Lin P, Lennon PA, Yin CC, Abruzzo LV. Chronic myeloid leukemia in blast phase associated with t(3;8)(q26;q24). Cancer Genet Cytogenet 193(2):119-22, 2009. PMID: 19665075.
161. Yin CC, Abruzzo LV, Qiu X, Apostolidou E, Cortes JE, Medeiros LJ, Lu G. Del(15q) is a recurrent "minor route" cytogenetic abnormality in the clonal evolution of chronic myelogenous leukemia. Cancer Genet Cytogenet 192(1):18-23, 2009. PMID: 19480932.
162. Yin CC, Lin KI, Ketterling RP, Knudson RA, Medeiros LJ, Barron LL, Huh YO, Luthra R, Keating MJ, Abruzzo LV. Chronic lymphocytic leukemia With t(2;14)(p16;q32) involves the BCL11A and IgH genes and is associated with atypical morphologic features and unmutated IgVH genes. Am J Clin Pathol 131(5):663-70, 2009. PMID: 19369625.
163. Zheng J, Huang J, Mao Y, Liu S, Sun X, Zhu X, Ma T, Zhang L, Ji J, Zhang Y, Yin CC, Qiu X. Immunoglobulin gene transcripts have distinct VHDJH recombination characteristics in human epithelial cancer cells. J Biol Chem 284(20):13610-9, 2009. e-Pub 2009. PMID: 19293154.
164. Lu G, Yin CC, Medeiros LJ, Abruzzo LV. Deletion 15q as the sole abnormality in acute myeloid leukemia: Report of three cases and review of the literature. Cancer Genet Cytogenet 188(2):118-23, 2009. PMID: 19100517.
165. Jones D, Thomas D, Yin CC, O'Brien S, Cortes JE, Jabbour E, Breeden M, Giles FJ, Zhao W, Kantarjian HM. Kinase domain point mutations in Ph+ acute lymphoblastic leukemia (ALL) emerge following therapy with BCR-ABL kinase inhibitors. Cancer 113(5):985-94, 2008. PMID: 18615627.
166. Huh YO, Lin KI, Vega F, Schlette E, Yin CC, Keating MJ, Luthra R, Medeiros LJ, Abruzzo LV. Myc translocation in chronic lymphocytic leukemia is associated with increased prolymphocytes and a poor prognosis. Br J Haematol 142(1):36-44, 2008. e-Pub 2008. PMID: 18477041.
167. Atallah E, Nussenzveig R, Yin CC, Bueso-Ramos C, Tam C, Manshouri T, Pierce S, Kantarjian H, Verstovsek S. Prognostic interaction between thrombocytosis and JAK2 V617F mutation in the WHO subcategories of myelodysplastic/myeloproliferative disease-unclassifiable and refractory anemia with ringed sideroblasts and marked thrombocytosis. Leukemia 22(6):1295-8, 2008. e-Pub 2007. PMID: 18059483.
168. Feng X, Ying J, Yin CC, Li L, Shi S, Zhang H, Sun Y. Diagnosis and differential diagnoses of granulocytic sarcoma. Chinese-German J Clin Oncol 7:603-7, 2008.
169. Cortes J, Jabbour E, Kantarjian H, Yin CC, Shan J, O'Brien S, Garcia-Manero G, Giles F, Breeden M, Reeves N, Wierda WG, Jones D. Dynamics of BCR-ABL kinase domain mutations in chronic myeloid leukemia after sequential treatment with multiple tyrosine kinase inhibitors. Blood 110(12):4005-11, 2007. e-Pub 2007. PMID: 17785585.
170. Lennon PA, Abruzzo LV, Medeiros LJ, Cromwell C, Zhang X, Yin CC, Kornblau SM, Konopleva M, Lin P. Aberrant EVI1 expression in acute myeloid leukemias associated with the t(3;8)(q26;q24). Cancer Genet Cytogenet 177(1):37-42, 2007. PMID: 17693189.
171. Yin CC, Medeiros LJ, Cromwell CC, Mehta AP, Lin P, Luthra R, Abruzzo LV. Sequence analysis proves clonal identity in five patients with typical and blastoid mantle cell lymphoma. Mod Pathol 20(1):1-7, 2007. e-Pub 2006. PMID: 17057651.
172. Salvato MS, Yin CC, Yagita H, Maeda T, Okumura K, Tikhonov I, Pauza CD. Attenuated disease in SIV-infected macaques treated with a monoclonal antibody against FasL. Clin Dev Immunol 2007:93462-6, 2007. PMID: 18317535.
173. Lin P, Medeiros LJ, Yin CC, Abruzzo LV. Translocation (3;8)(q26;q24): a recurrent chromosomal abnormality in myelodysplastic syndrome and acute myeloid leukemia. Cancer Genet Cytogenet 166(1):82-5, 2006. PMID: 16616115.
174. Yin CC, Cortes J, Barkoh B, Hayes K, Kantarjian H, Jones D. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy. Cancer 106(8):1730-8, 2006. PMID: 16532439.
175. Merzianu M, Medeiros LJ, Cortes J, Yin CC, Lin P, Jones D, Glassman A, Kantarjian H, Huh Y. inv(16)(p13q22) in chronic myelogenous leukemia in blast phase - A clinicopathologic, cytogenetic, and molecular study of five cases. Am J Clin Pathol 124(5):807-14, 2005. PMID: 16203287.
176. Yin CC, Glassman AB, Lin P, Valbuena JR, Jones D, Luthra R, Medeiros LJ. Morphologic, cytogenetic, and molecular abnormalities in therapy-related acute promyelocytic leukemia. Am J Clin Pathol 123(6):840-8, 2005. PMID: 15899774.
177. Yin CC, Lin P, Carney DA, Handy BC, Rassidakis GZ, Admirand JH, Keating MJ, Medeiros LJ. Chronic lymphocytic leukemia/small lymphocytic lymphoma associated with IgM paraprotein. Am J Clin Pathol 123(4):594-602, 2005. PMID: 15743747.
178. Yin CC, Medeiros LJ, Abruzzo LV, Jones D, Farhood AI, Thomazy VA. EBV-associated B- and T-cell posttransplant lymphoproliferative disorders following primary EBV infection in a kidney transplant recipient. Am J Clin Pathol 123(2):222-8, 2005. PMID: 15842046.
179. Yin CC, Medeiros LJ, Glassman AB, Lin P. t(8;21)(q22;q22) in blastic phase of chronic myelogenous leukemia. Am J Clin Pathol 121(6):836-42, 2004. PMID: 15198355.
180. Yin CC, Chapman J, Tawfik O. Invasive mucinous (colloid) adenocarcinoma of ectopic breast tissue in the vulva: a case report. Breast J 9(2):113-5, 2003. PMID: 12603384.
181. Enders PJ*, Yin C*, Martini F, Evans PS, Propp N, Poccia F, Pauza CD (*These two authors contributed equally to this work). HIV-mediated gammadelta T cell depletion is specific for Vgamma2+ cells expressing the Jgamma1.2 segment. AIDS Res Hum Retroviruses 19(1):21-9, 2003. PMID: 12581513.
182. Djavani M, Yin C, Lukashevich IS, Rodas J, Rai SK, Salvato MS. Mucosal immunization with Salmonella typhimurium expressing Lassa virus nucleocapsid protein cross-protects mice from lethal challenge with lymphocytic choriomeningitis virus. J Hum Virol 4(2):103-8, 2001. PMID: 11437313.
183. Evans PS, Enders PJ, Yin C, Ruckwardt TJ, Malkovsky M, Pauza CD. In vitro stimulation with a non-peptidic alkylphosphate expands cells expressing Vgamma2-Jgamma1.2/Vdelta2 T-cell receptors. Immunol 104(1):19-27, 2001. PMID: 11576216.
184. Djavani M, Yin C, Xia L, Lukashevich IS, Pauza CD, Salvato MS. Murine immune responses to mucosally delivered Salmonella expressing Lassa fever virus nucleoprotein. Vaccine 18(15):1543-54, 2000. PMID: 10618553.
185. Yin C, Wu MS, Pauza CD, Salvato MS. High major histocompatibility complex-unrestricted lysis of simian immunodeficiency virus envelope-expressing cells predisposes macaques to rapid AIDS progression. J Virol 73(5):3692-701, 1999. PMID: 10196261.
186. Yin C, Djavani M, Schenkel AR, Schmidt DS, Pauza CD, Salvato MS. Dissemination of lymphocytic choriomeningitis virus from the gastric mucosa requires G protein-coupled signaling. J Virol 72(11):8613-9, 1998. PMID: 9765400.
187. Pauza CD, Hinds PW 2nd, Yin C, McKechnie TS, Hinds SB, Salvato MS. The lymphocytosis-promoting agent pertussis toxin affects virus burden and lymphocyte distribution in the SIV-infected rhesus macaque. AIDS Res Hum Retroviruses 13(1):87-95, 1997. PMID: 8989431.
188. Hinds PW 2nd, Yin C, Salvato MS, Pauza CD. Pertussis toxin induces lymphocytosis in rhesus macaques. J Med Primatol 25(6):375-81, 1996. PMID: 9210021.
189. Yin C, Zhang BX, Zheng J, Wu B. Combined antitumor effect of tumor-infiltrating lymphocytes and tumor necrosis factor alpha. Chinese J Pathol 24(3):162-4, 1995. PMID: 7656383.
190. Yin C, Zhang BX, Zheng J, Wu B. Comparison of the antitumor effect of tumor-infiltrating lymphocytes and tumor-involved lymph node lymphocytes. J Beijing Med Univ 27 (supple):23-5, 1995.
191. Zhang BX, Tang Y, Yin C, Zheng J, Wu B. Experimental expansion and antitumor effect of LAK cells from cancer patient's peripheral blood. Chinese J Cancer 14(4):253-6, 1992.
192. Zhang BX, Yin C, Tao J, Wu B. Observation on the phenotypic changes of tumor-infiltrating lymphocytes (TIL) during cultivation in vitro. Chinese J Pathol 21(5):281-3, 1992.
193. Zhang BX, Yin C, Tang Y, Wu B. The antitumor effect of tumor-infiltrating lymphocytes (TIL) being proliferated in vitro. Chinese J Pathol 21(2):79-81, 1992.
194. Zhang BX, Tang Y, Zheng J, Yin C, Wang J, You J, Fang W, Wu B, Wang X, Gao R. Researches on the anti-autologous tumor effects of human cancer-killing cells in nude mice. Chinese J Cancer Res 4(4):30-2, 1992.
195. Hu F, Zheng J, Zhang L, Han W, Zhao L, Ma T, Geng L, Huang J, Yin CC, Qiu X. Toll-like receptor 9 agonists could promote human epithelial cancer cells to express and secrete immunolgobulin M.
196. Zheng J, Chu M, Ye Q, Huang J, Zhe P, Zhang L, Mao Y, Zhang Z, Zhu X, Shi C, Zhang Y, Yin CC, Fu N, Qiu X. Unique VK4-1/JK3 recombination of immunoglobulin kappa light chain widely expressed in nonlymphoid cells of different tissue origins.
197. Zhang C, Zhang X, Rangwala S, Yin CC, Pronk B, Duvic M. Pralatrexate selectively induces apoptosis and synergizes with bexarotene through up-regulation of p53/bax/PUMA in CTCL cells and a mouse xenograft model.
198. Chu M, Wang C, Zheng J, Ye Q, Jiang D, Huang J, Zhang L, Zhu P, Shi C, Wu S, Zhang Y, Yin CC, Zhang Y, Fu N, Qiu X. A hydrophobic immunoglobulin kappa light chain with unique VK4-1/JK3 rarrangement is widely expressed in different tissues as a potential cytoskeleton-related protein.
199. Liu Y, Zhang J, Liu D, Zhu X, Wang C, Liao Q, Huang J, Jiang D, Shao W, Sheng Z, Yin CC, Zhang Y, Lee G, Qiu X. Involvement of immunoglobulin G in progression of lung squamous cell carcinoma as a novel marker.
200. Kanagal-Shamanna R, Luthra R, Luthr M, Lu X, Routbort MJ, Estrov Z, Jain P, Yin CC, Zuo Z, Bueso-Ramos C, Singh RR, Jain N, Keating M, Medeiros LJ, Wierda W, Patel KP. Chronic lymphocytic leukemia/small lymphocytic lymphoma with RAS/RAF mutation is frequently associated with trisomy 12 and unmutated IGHV gene.
201. Ok CY, Loghavi S, Salim AA, Raja L, Routbort MJ, Singh RR, Zuo Z, Wang S, Jorgensen JL, Stingo F, Kanagal-Shamanna R, Yin CC, DiNardo C, Pierce SA, Garica-Manero G, Kantarjian HM, Cortes J, Ranvandi-Kashani F, Michael A, Medeiros LJ, Patel KP. DNMT3A mutation independently predicts relapse in patients with acute myeloid leukemia in morphologic remission.
202. Khan M, Kantarjian H, Yin CC, KiNardo CD, Naqvi K, Short N, Ravandi F, Borthakur G, KInopleva M, Andreeff M, Cortes J, Benton CB. Disease characteristics and patient outcomes in BCR-ABL-positive acute myeloid leukemia. Leuk Res.
203. Wang C, Chu M, Ye Q, Jiang D, Zheng J, Xia M, Liu Y, Huang J, Zhang L, Zhu P, Shi C, Tan gJ, Ma J, Wu S, Liu Y, Geng Z, Zhang Y, Yin CC, Zhang Y, Fu N, Qiu X. A wildly expressed immunoglobulin free light chain with Vκ4-1/Jκ3 rearrangement promotes cancer metastasis.
204. Yang H, Zuo Z, Loghavi S, Class C, Wei Y, Singh R, Sui D, Wei P, Routbort M, Yin CC, Kanagal-Shamanna R, Jabbour EJ, Bhalla K, Garcia-Manero G, Kantarjian HM, Medeiros LJ, Luthra R, Khoury JD. Genomic and expression profiling of PDE4DIP (myomegalin) in chronic myelomonocytic leukemia highlights a potential pathogenic role for anchoring proteins in myeloid malignancies.
205. Yang Y, Fowler N, Ma L, Zhang Y, Bueso-Ramos C, Goswami R, Liang Y, Jin J, Yin CC, Yuan T, He H, Huang X, Jin P, Zhang YH, Miranda R, Yao J, Rodriguez-Aguayo C, Lopez-Berestein G, Rossi S, Zhao H, Borthakur G, Medeiros LJ, Zhang C, Calin G, Han X, You MJ. Dual Negative Inhibition of MYC and PI3K by miRNA-150 Tumor Suppressor in T-Cell Acute Lymphoblastic Leukemia.
206. Tang Z, Wang W, Zhao P, Liu W, Toruner GA, Yin CC, Hu S, Thakral B, Wang SA, Patel KP, Lu X, Khoury JD, Medeiros LJ, Tang G. Additional Structural Chromosomal Abnormalities Have a Negative Prognostic Effect in Patients with inv(16)/t(16;16) Acute Myeloid Leukemia.
207. Jain P, Zhao S, Kanagal-Shamanna R, Navsaria L, Hill HA, Nomie K, Jiang C, Yao Y, Nastoupil L, Westin J, Fayad L, Nair R, Steiner R, Ahmed S, Samaniego F, Iyer SP, Oriabure O, Chen W, Badilo M, Tang G, Yin CC, Patel K, thirumurthi S, Xu G, Neelapu S, Flowers C, Romaguera J, Fowler N, Wang L, Wang ML. Non-BCL2 mutations are predominant in patients with venetoclax resistant mantle cell lymphoma – outcomes in ultra-refractory patients. Am J Hematol.
208. Sakhdari A, Loghavi S, Garces S, Patel KP, Yin CC, Thakral B, Kanagal R, Medeiros LJ, Khoury J. Integrative Analysis of Histiocytic Sarcoma Demonstrates Frequent P53 Dysregulation with Concomitant MAPK Pathway Activation.
209. Quesada AE, Montalban-Bravo G, Medeiros LJ, Luthra R, Patel KP, Bueso-Ramos CE, Khoury JD, Routbort MJ, Bassett R, Hidalgo-Lopez JE, Zhao C, Lin P, Yin CC, Zuo Z, Loghavi S, Ok CY, Kadia T, DiNardo C, Sasaki K, Kantarjian HM, Garcia-Manero G, Kanagal-Shamanna R. Clinico-pathologic characteristics and outcomes of the World Health Organization (WHO) provisional entity de novo Acute Myeloid Leukemia with mutated RUNX1.
210. Yan H, Wu L, Wang P, Xia M, Shi Z, Huang X, Yin S, Huang J, Dai H, Deng L, Jiang Q, Yin CC*, Zhao X*, Qiu X*. A comparative analysis of immunoglobulin repertoire in leu-kemia cells and B cells in Chinese acute myeloid leukemia by high-throughput sequencing (*Co-corresponding).

Invited Articles

1. Zuo Z, Li S, Xu J, You MJ, Khoury JD, Yin CC. Philadelphia-negative Myeloproliferative Neoplasms: Laboratory Workup in the Era of Next-generation Sequencing. Curr Hematol Malig Rep 14(5):376-385, 2019. PMID: 31388824.
2. Yin CC, Luthra R. Molecular detection of t(11;14)(q13;q32) in mantle cell lymphoma. Methods Mol Biol 999:211-6, 2013. PMID: 23666700.
3. Yin CC, Luthra R. Molecular detection of t(14;18)(q32;q21) in follicular lymphoma. Methods Mol Biol 999:203-9, 2013. PMID: 23666699.
4. Yin CC, Luthra R. Detection of t(2;5)(p23;q35) in anaplastic large-cell lymphoma by long-range nested polymerase chain reaction assay. Methods Mol Biol 999:217-22, 2013. PMID: 23666701.
5. Yin CC, Medeiros LJ, Bueso-Ramos CE. Recent advances in the diagnosis and classification of myeloid neoplasms - Comments on the 2008 WHO classification. Int J Lab Hematol 32(5):461-76, 2010. e-Pub 2010. PMID: 20626469.
6. Yin CC, Jones D, Cortes J, Kantarjian H, Medeiros LJ, Bueso-Ramos CE.. Type B CBFb/MYH11 fusion transcript in de novo myeloid blast phase of chronic myeloid leukemia: Correlation with nuclear and cytoplasmic localization of the fusion protein. Clin Leukemia 2(4):257-60, 2008.
7. Yin CC, Jones D. Molecular approaches towards characterization, monitoring and targeting of viral-associated hematological malignancies. Expert Rev Mol Diagn 6(6):831-41, 2006. PMID: 17140370.

Other Articles

1. Yin CC Role of MHC-unrestricted lysis in the pathogenesis and immunotherapy of human/simian immunodeficiency virus infection (Postdoctoral thesis), 1999.
2. Yin CC Targeted tumor immunotherapy using tumor-infiltrating lymphocytes (Master thesis), 1993.

Editorials

1. Chen F, Yin CC. Preface to the Special Issue of Oncology. N Am J Med Sci 5(1):1, 2012.
2. Yin CC. Detection and Molecular Monitoring of Minimal Residual Diseases in Acute Myeloid Leukemias. J Mol Biomark Diagn 3(2):e106, 2012.
3. Yin CC. Detection and Molecular Monitoring of Minimal Residual Disease in Chronic Myelogenous Leukemia. J Clin Exp Pathol 2(4):e110, 2012.

Abstracts

1. Hu Z, Yin CC, Wang WJ, Lin P, Glass WF, Medeiros LJ, You MJ. AL Amyloidosis with Associated Low-Grade B-Cell Lymphoma: A Report of 18 Cases. USCAP 2022, 2022.
2. Wang L, Thompson M, Mason EF,.. Yin CC,.. Yerrapotu N, Czader MB. Age-related genomic landscape of T lymphoblastic leukemia/lymphoma. USCAP 2022, 2022.
3. Nwogbo OV, Hao S, Hu S, Li S, Xu J, Yin CC, Bueso-Ramos C. Tang G, Medeiros LJ, Lin P. Prognostic Impact of 8q24/MYC Rearrangement in Myeloma in the Era of Novel Therapy. USCAP 2022, 2022.
4. Ok CY, Jain P, Floyd K, Loghavi S, Kanagal-Shamanna R, Zuo Z, Yin CC, Routbort MJ, Luthra R, Wang ML, Medeiros LJ, Patel KP. EndLymphoma Assay v1: Enabling NGS-Based Comprehensive Routine Molecular Profiling of Mantle cell lymphoma in Routine Clinical Care. ASH 2021, 2021.
5. Yeung RA, Russell V, Choi W,.. Yin CC,.. Dave S. ALK-negative ALCLs encompass distinct subgroups including an ALK-positive like subgroup with favorable prognosis. ASH 2021, 2021.
6. Mohamed SF, Khan M, Quesada AE, Ma J, Lin P, Yin CC, Sasaki K, Borthakur G, Pemmaraju N, Bashir Q, Qazilbash MH, Kaufman GP, Becnel M. Disease Characteristics of Multiple Myeloma Involving BRAF Mutations. ASH 2021, 2021.
7. Au-Yeung RKH, Choi W, Wong A, xxx, Li S, Xu J, Yin CC,.. Naresh KN, Love C, Tse E. ALK-Negative Anaplastic Large Cell Lymphomas Encompass Distinct Subgroups Including an ALK-Positive-like Subgroup with Favorable Prognosis. ASH 2021, 2021.
8. Yin CC, Lin P, Li S, Xu J, You MJ, Bueso-Ramos CE, Medeiros LJ, Wang SA. Relapsed B-ALL with aberrant MPO expression following CAR T-cell therapy. EAHP 2021 Bone Marrow Workshop, 2021.
9. Khanlari M, Xu J, Lin P, You MJ, Yin CC, Qiu L, Medeiros LJ, Li S. Triple hit high grade B-cell Lymphoma with blastoid morphology. SH/EAH 2021, 2021.
10. Qiu L, Kharlari M, Li S, Tang G, Yin CC, Wang S, Iyer S, You MJ, Konoplev SN, Miranda RN, Medeiros LJ, Xu J. Leukemic ALK-negative ALCL is characterized by thrombocytopenia, bone marrow involvement, CD7 positivity, complex karyotype, and a poor prognosis. DPLM 1st Annual Research Symposium, 2021.
11. Nezami B, Toruner G, Routbort M, San Lucas F, Yang R, Seyedjafari R, Chen H, Rashid A, Loghavi S, Roy S, Kanagal-Shamanna R, Yin CC, Zuo Z, Ok CY, Tang Z, Medeiros LJ, Luthra R, Patel KP. Clinical Utility of NGS-based gene fusion testing in solid tumors. DPLM 1st Annual Research Symposium, 2021.
12. Shuai W, Chen W, Floyd K, Routbort M, San Lucas F, Kanagal-Shamanna R, Zuo Z, Loghavi S, Ok CY, Yin CC, Luthra R, Medeiros LJ, Patel KP. Ultra-rapid reporting of TP53 mutation in myeloid neoplasms by using next generation sequencing. DPLM 1st Annual Research Symposium, 2021.
13. Yang Y, Bueso-Ramos C, Yin CC, Zhang H, Miranda RN, Borthakur G, Medeiros LJ, Calin GA, Han X, You MJ. Down-regulation of miR-150 and its inhibition on the growth of T cell acute lymphoblastic leukemia. DPLM 1st Annual Research Symposium, 2021.
14. Khanlari M, Li S, Medeiros LJ, Iyer S, Yin CC, Lin P, Tang G, Konoplev SN, Miranda RN, Xu J. Small cell/lymphohistiocytic morphology is associated with CD8 positivity, retained T cell markers, a trend of decreased PD-L1 expression, but not outcome in adults with ALK+ ALCL. DPLM 1st Annual Research Symposium, 2021.
15. Qiu L, Khanlari M, Li S, Tang G, Yin CC, Wang SA, Iyer S, You MJ, Konoplev SN, Miranda RN, Medeiros LJ, Xu J. Leukemic ALK-negative ALCL is Characterized by Thrombocytopenia, Bone Marrow Involvement, CD7 Positivity, Complex Karyotype, and a Poor Prognosis. Mod Pathol, 2021.
16. Khanlari M, Lin P, Xu J, You MJ, Tang G, Yin CC, Qiu L, Bueso-Ramos CE, Medeiros LJ, Li S. Blastoid Large B Cell Lymphoma with Primary Bone Marrow Presentation: A Diagnostic Challenge. Mod Pathol, 2021.
17. Wen S, Chen W, Floyd K, Routbort M, Lucas AS, Kanagal-Shamanna R, Zuo Z, Loghavi S, Ok C, Yin CC, Luthra R, Medeiros LJ, Patel KP. Ultra-Rapid Reporting of TP53 Mutation by Next Generation Sequencing. Mod Pathol, 2021.
18. Nezami BG, Torruner G, Routbort MJ, Lucas AS, Alvarez H, Yang R, Seyedjafari R, Chen H, Rashid A, Loghavi S, Roy SC, Kanagal-Shamanna R, Yin CC, Zuo Z, Ok CY, Tang Z, Medeiros LJ, Luthra R, Patel KP. Clinical Utility of NGS-Based Gene Fusion Testing in Solid Tumors. Mod Pathol, 2021.
19. Jain P, Tang G, Yin CC, OK CY, Navsaria L, Badillo M, Chen W, Onyeka Oriabure O, Gonzalez GN, Westin J, Nastoupil L, Sairah Ahmed S, Nair R, Thirumurthi S, Li S, Kanagal-Shamanna R, Vega F, Flowers C, Wang ML. Complex karyotype is a significant predictor for worst outcomes in patients with mantle cell lymphoma (MCL) treated with BTK inhibitors – comprehensive analysis of 396 patients. ASH 2020, 2020.
20. Jain P, Zhang S, Kanagal-Shamanna R, Navsaria L, Ok CY, Tang G, Yin CC, Badillo M, Chen W, Oriabure O, Lee HJ, Westin J, Nastoupil L, Moghrabi O, Che Y, Samaniego F, Ahmed S, Nair R, Li S, Vega F, Flowers C, Wang L, Wang ML. Outcomes of acalabrutinib failures in relapsed mantle cell lymphoma. ASH 2020, 2020.
21. Jain P, Yao Y, Zhao S, Liu Y, Hill HA, Che Y, Li Y, Jordan A, MdIntosh J, Lee HJ, Steiner R, Samaniego F, Westin J, Nastoupil L, Nair R, Ahmed S, Ok CY, Kanagal-Shamanna R, Oriabure O, Xu G, Chen W, Moghrabi OB, McClain C, Badillo M, Thirumurthi S, Santos D, Yin CC, Li S, Tang G, Vega F, Neelapu S, Flowers C, Wang L, Wang ML. Combination of ibrutinib with rituximab (IR) in previously untreated elderly patients with mantle cell lymphoma (MCL) – a phase II clinical trial. ASH 2020, 2020.
22. Wang ML, Jain P, Yao Y, Liu Y, Zhao S, Hill HA, Liu Y, Moghrabi OB, Lee HJ, Samaniego F, Westin J, Nastoupil L, Kanagal-Shamanna R, OK CY, Chen W, Oriabure O, Che Y, Li Y, Feng L, Gonzalez GN, Xu G, Wagner-Bartak N, Thirumurthi S, Santos D, Tang G, Vega F, Yin CC, Avellaneda M, Badillo M, Flowers C, Wang L. Ibrutinib plus rituximab (IR) followed by short course R-HyperCVAD/MTX in patients (age ≤ 65 years) with previously untreated mantle cell lymphoma – phase-II WINDOW-1 clinical trial. ASH 2020, 2020.
23. Jain P, Yao Y, Jiang C, Liu Y, Hill HA, Che Y, Li Y, Lee HJ, Steiner R, Samaniego F, Nair R, Ahmed S, OK CY, Kanagal-Shamanna R, Oriabure O, Chen W, Xu G, Khoury SCE, Badillo M, Yin CC, Li S, Tang G, Vega F, Flowers C, Wang L, Wang ML. Phase II Trial of ibrutinib in previously untreated high risk smoldering mantle cell lymphoma. ASH 2020, 2020.
24. Kanagal-Shamanna R, Kantarjian H, Khoury J, Takahashi K, Montalban-Bravo G, Short NJ, Yin CC, Patel KP, Loghavi S, DiNardo C, Ravandi F, Konopleva M, Jain N, Garcia-Manero G, Daver N, Kadia T, O'Brien S, Luthra R, Jabbour E. Distinct Prognostic Effects of TP53 Mutations in Newly Diagnosed Versus Relapsed/Refractory (R-R) Patients (pts) with B-Acute Lymphoblastic Leukemia (ALL) Treated with Mini-HCVD-Inotuzumab Ozogamicin with or without Blinatumomab Regimens (selected as "Top-25 abstract). ASH 2020, 2020.
25. Rafei H, Yin CC, Jabbour EJ. Impact of Cytogenetic Abnormalities (CA) on Outcome of Patients (Pts) with Relapsed/Refractory (R-R) Acute Lymphoblastic Leukemia (ALL) Treated with Inotuzumab Ozogamicin (INO) in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) with or without Blinatumomab: Results from a Phase 2 Study. ASH 2020, 2020.
26. Yang RK, Tang Z, Tang G, Toruner GA, Yin CC, Wang W, Hu S, Zuo Z, Patel KP, Khoury JD, Medeiros LJ. Atypical CBFB FISH Signal Patterns Warrant Further Investigation for a True CBFB Rearrangement: an Analysis of 2425 CBFB FISH Tests. AMP 2020, 2020.
27. Khanlari M, Li S, Miranda RN, Iyer S, Yin CC, Lin P, Tang G, Konoplev SN, Medeiros LJ, Xu J. Small cell/lymphohistiocytic morphology is associated with CD8 positivity, retained T cell markers, a trend of decreased PD-L1 expression, but not outcome in adults with ALK+ ALCL. Society for Immunotherapy of Cancer 35th Annual Meeting, 2020.
28. Khanlari M, Li S, Medeiros LJ, Yin CC, Lin P, Tang G, Iyer S, Konoplev SN, Miranda RN, Xu J. Small Cell/Lymphohistiocytic Morphology is Associated with CD8 Positivity and Retained T Cell Markers but not Outcome in Adults with ALK+ ALCL. USCAP 2020, 2020.
29. Khanlari M, Loghavi S, Wang SA, El Hussain S, Tashakori M, Bueso-Ramose CE, Yin CC, Kanagal-Shamanna R, Khoury JD, Medeiros LJ, Patel KP, Popat UR, Konoplev S. The Significance of Bone Marrow Morphologic Features for Surveillance of Patients with Myelofibrosis Following Molecular Clearance After Stem Cell Transplant. USCAP 2020, 2020.
30. Garces S, Piubelli MLM, Siquiera SAC, Sriganeshan V, Medina AM, Castellano-Sanchez A, Poppiti R, Khoury JD, Li S, Xu J, Saluja K, Bhattacharjee MB, Medeiros LJ, Yin CC. Cyclin D1 protein is overexpressed in Rosai-Dorfman disease. Mod Pathol, 2019.
31. Xu J, Wang S. Wang L, Tang G, Lin P, Yin CC, Medeiros LJ, Li S. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma-Like Mantle Cell Lymphoma. Mod Pathol, 2019.
32. Ok CY, Chen Z, Loghavi S, Kanagal-Shamanna R, Zuo Z, Yin CC, Routbort M, Patel KP, Luthra R, Medeiros LJ, Wang S. Prevalence and Clinical Implication of Splicing Factor Gene Mutation in Patients with Primary Myelofibrosis. Mod Pathol, 2019.
33. Hidalgo-Lopez JE, Bueso-Ramos C, Khoury JD, Yin CC, Miranda RN, Huh Y, Thakral B, Wang WB, Medeiros LJ, Kanagal-Shamanna R. Metastatic Angiosarcoma Initially Diagnosed In the Bone Marrow. Mod Pathol, 2019.
34. Shen J, Li S, Yin CC, Wang S, Lin P, Jorgensen J, Tang G, Hu S, Medeiros LJ, Xu J. CD8 Expression in Anaplastic Large Cell Lymphoma Identifies a Subgroup with Advanced Stage, Non-common Morphology, Unique Phenotype, and Poorer Outcome. Mod Pathol, 2019.
35. Xie W, Sakhdari A, Loghavi S, Kanagal-Shamanna R, Zuo Z, Yin CC, Routbort MJ, Patel KP, Luthra R, Medeiros LJ, Ok CY. The Result of 122 Consecutive NGS-based Analysis of T-Lymphoblastic Leukemia/Lymphoma and Early T-cell Precursor Leukemia (ETP). Mol Diagn, 2019.
36. Jelloul FZ, Wang P, Yang R, Kanagal-Shamanna R, Ok CY, Loghavi S, Routbort MJ, Zuo Z, Yin CC, Floyd K, Wierda W, Luthra R, Medeiros LJ, Patel KP. Non-coding NOTCH1 mutations in chronic lymphocytic leukemia. Mol Diagn, 2019.
37. Konoplev S, Thakral B, Yin CC, Li S, Lin P. Aggressive NK-cell leukemia. Chinese Society for Hematopathology/Society for Hematopathology Workshop 2019 - Infectious Agent-Associated Lymphoid Proliferations, 2019.
38. Wang ML, Jain P, Lee HJ, Hagemeister F, Samaniego F, Westin J, Nastoupil L, Chen W, Nomie K, Zhao S, Moghrabi OB, Zhao S, Kanagal-Shamanna R, Ok CY, Oriabure O, Gonzalez GN, Jung D, Navsaria L, Zhang L, Jiang C, Yao Y, Xu G, Wagner-Bartak N, Thirumurthi S, Santos D, Tang G, Patel KP, Yin CC, Avellaneda M, Badillo M, Fayad L, Neelapu S, Fowler N, Wang L, Romaguera J. Frontline treatment with ibrutinib plus rituximab (IR) followed by short course R-HyperCVAD/MTX is extremely potent and safe in patients (age ≤ 65 years) with mantle cell lymphoma (MCL) – results of phase-II WINDOW-1 clinical trial. Blood, 2019.
39. Jain P, Zhao S, Kanagal-Shamanna R, Navsaria L, Hill HA, Nomie K, Misra A, Jiang C, Yao Y, Zhang L, Nastoupil L, Hagemeister F, Westin J, Nair R, Steiner R, Oriabure O, Chen W, Tang G, Yin CC, Patel KP, Romaguer J, Fowler N, Wang L, Wang ML. Non-Bcl2 mutations are predominant in patients (pts) with venetoclax resistant mantle cell lymphoma (MCL) – response and clinical outcomes in ultra-refractory MCL. Blood, 2019.
40. Lyapichey K, Medeiros LJ, Li S, Yin CC, Tang G, You MJ, Konoplev SN, Bueso-Ramos C, Miranda R, Xu J. MYC Expression in Systemic Anaplastic Large Cell Lymphoma: Clinicopatbologic and Prognostic Features of 70 Patients. Blood, 2019.
41. Richard-Carpentier G, Kantarjian HM, Tang G, Yin CC, Khoury J, Issa G, Jain N, Ravandi F, Short NJ, DiNardo CD, Takahashi K, Ohanian M, Borthakur G, Konopleva MY, Daver NG, Estrov Z, Alvarado Y, Ferrajoli A, Kadia T, Garcia-Manero G, Verstovsek S, Garris R, Cortes J, O'Brien S, Jabbour E. Characteristics and Clinical Outcomes of Patients with Acute Lymphoblastic Leukemia with KMT2A (MLL) rearrangement. Blood, 2019.
42. Li X, Kositsky R, Reddy A,.. Yin CC,.. Dave S. Whole exome and transcriptome sequencing in 1042 cases reveals distinct clinically relevant genetic subgroups of Follicular Lymphoma. Blood 134(Suppl 1):19, 2019.
43. Pemmaraju N, Kantarjian HM, Khoury JD, Loghavi S, O'Brien S, Cortes JE, Garcia-Manero G, Jabbour E, Verstovsek S, Jain N, Duvic M, Aung P, Yin CC, Konoplev S, Patel KP, Pierce SA, Beird H, Qazilbash MH, Konopleva MY. Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Commonly Presents in the Setting of Prior or Concomitant Hematologic Malignancies (PCHM): Patient Characteristics and Outcomes in the Rapidly Evolving Modern Targeted Therapy Era. Blood, 2019.
44. Veletic I, Yin CC, Verstovsek S. Spatial Distribution of Bone Marrow T-Cells and Antigen Presenting Cells Correlates with Inflammation and Disease Burden in Patients with Primary Myelofibrosis. Blood, 2019.
45. Tang Z, Tang G, Toruner GA, Yang S, Yin CC, Khoury J, Miranda R, Medeiros LJ. BCR/ABL1 Fusion by Chromosomal Insertion: an Analysis of 15 Cases. ACMG Annual Meeting, 2019.
46. Garces S, Huang W, Li S, Hu S, Wang W, Yin CC, Xu J, Medeiros LJ, Lin P. Clinicopathologic and immunophenotypic features of MYD88 L265P– positive Lymphoplasmacytic lymphoma/Waldenström Macroglobulinemia: A study of 30 cases. Mod Pathol, 2018.
47. Xu J, Saksema A, Wang L, Yin CC, Wang SA, Hu Z, Lin P, Tang G, Medeiros LJ, Li S. Characterization of SOX11-negative mantle cell lymphoma: Clinicopathologic and prognostic features of 53 patients. Mod Pathol, 2018.
48. He J, Lu X, Li S, Hu S, Wang W, Yin CC, Lin P. Multiple myeloma with t(14;16) MAF-IGH is associated with other high risk Genetic features. Mod Pathol, 2018.
49. Hu B, Patel K, Chen H, Wang X, Luthra R, Routbort M, Kanagal-Shamanna R, Medeiros LJ, Yin CC, Zuo Z, Ok C, Loghavi S, Thompson PA, Keating MJ, Burger JA, Jain N, Ferrajoli A, Bose P, Estrov Z, Wierda WG. ATM mutation and unmutated IGHV status are the strongest predictors of time to first treatment: An analysis of multigene profiling for 384 treatment-naive chronic lymphocytic leukemia (CLL) patients. 2018 ASCO Annual Meeting, 2018.
50. Ruiz-Cordero R, Floyd K, Loghavi S, Kanagal-Shamanna R, Yin CC, Zuo Z, Routbort MJ, Luthra R, Kantarjian HM, Medeiros LJ, Patel KP, Ok CY. PTPN11 mutation is uncommon in acute myeloid leukemia, but associated with a complex karyotype, co-mutations in KRAS or NRAS and poor prognosis. J Mol Diagn, 2018.
51. Garces S, Yin CC, Patel KP, Khoury JD, Manning JT, Li S, Xue J, Medeiros LJ. Rosai-Dorfman disease co-existing with lymphoma in the same lymph node: a localized histiocytic proliferation with MAPK/ERK pathway-induced cyclin D1 upregulation. J Mol Diagn, 2018.
52. Shen J, Li S, Lin P, Yin CC, Tang G, Jorgensen JL, Wang SA, Xue J. CD8-positive anaplastic large cell lymphoma. International Clinical Cytometry Society 2018, 2018.
53. Verstovsek S, Mesa R, Pozdnyakova O, Hasserjian R, Mascarenhas J, Foltz L, Ritchie E, Silver R, Kermyanskaya M, Veletic I, Manshouri T, Yin CC, Estrov Z, Vandenblink B, Gupta R, Gotlib J. PRM-151 in myelofibrosis: Efficacy and safety in an open label extension study (oral presentation). Blood, 2018.
54. Sakhdari A, Logahvi S, Kanagal-Shamanna R, Yin CC, Zuo Z, Routbort MJ, Patel KP, Luthra R, Medeiros LJ, Ok CY. Incorporation of TP53 Gene Mutation in Genetic Risk Stratification of Adult T-Cell Lymphoblastic Leukemia (T-ALL) Better Predicts Survival. Blood, 2018.
55. Pemmaraju N, Kantarjian HM, Khoury JD, O'Brien SM, Cortes JE, Garcia-Manero G, Jabbour E, Jain N, Aung P, Yin CC, Konoplev SN, Patel KP, Pierce S, Zhou L, Konopleva M. Outcomes in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Longer-Term Follow-Up Demonstrates Poor Outcomes in Patients with Skin-Only Presentation. Blood 132:3980, 2018.
56. Manshouri T, Veletic I, Yin CC, Chen L, Bose JE, Zhang Y, Verstovsek S, Estrov Z. Bone Marrow Fibrocytes Overexpress Gli1 Oncogenic Transcription Factor in Primary Myelofibrosis. Blood, 2018.
57. Xu J, Saksena A, Zhou J, Li J, Yin CC, Tang G, Medeiros LJ, Li S. CD10-positive mantle cell lymphoma: clinicopathologic and prognostic study of 28 cases. Mod Pathol, 2017.
58. Saksena A, Li J, Yin CC, Lin P, Zhou J, Miranda R, Li S. CD23-positive mantle cell lymphoma: a linicopathologic analysis of 59 cases. Mod Pathol, 2017.
59. Garces S, Medeiros LJ, Patel KP, Li S, Pina-Oviedo S, Li J, Khoury JD, Yin CC. Recurrent KRAS and MAP2K1 mutations detected in Rosai-Dorfman disease by next-generation sequencing. Mod Pathol, 2017.
60. Liu H, Yin CC, Wang SA, Xu J, Medeiros LJ, Tang G. Clinicaopathologic features of adult myeloid neoplasm with t(16;21). Mod Pathol, 2017.
61. Gur D, Loghavi S, Routbort M, Garcia-Manero G, Yin CC, Li S, Medeiros LJ, Khoury JD. JAK2 p.V617F mutation is common in chronic myelomonocytic leukemia with fibrosis. Mod Pathol, 2017.
62. Yin CC, Patel KP, Zuo Z, Wang SA, Li S, Medeiros LJ, Bueso-Ramos CE. Acute promyelocytic leukemia with novel IRF2BP2-RARA fusion. SH/EAHP, 2017.
63. Li S, Tang G, Wang SA, Konoplev S, Yin CC, Xu J, Medeiros LJ, Lin P. B-lymphoblastic leukemia with CRLF2 rearrangement and JAK2 mutation. SH/EAHP, 2017.
64. Li S, Xu J, Yin CC, Khoury J, Medeiros LJ, Bueso-Ramos CE, Lin P. Refractory myelodysplastic syndrome with JAK2 mutation. SH/EAHP, 2017.
65. Hu Z, Konoplev S, Li S, Yin CC, Lopez JEH, Bueso-Ramos CE. Primary myelofibrosis presenting with marked monocytosis mimicking chronic myelomonocytic leukemia at initial presentation. SH/EAHP, 2017.
66. Yin CC, Li J, Li S, Xu J, Li N, Jorgensen JL, Lin P, Bueso-Ramos CE, Medeiros LJ. Philadelphia chromosome-positive acute leukemia with an early T-cell precursor immunophenotype. SH/EAHP, 2017.
67. Yin CC, Li N, Li S, Zuo Z, Li J, Young KH, Medeiros LJ, Bueso-Ramos CE. Chronic myeloid leukemia, preleukemic phase, with t(9;22)(q34;q11.2)/BCR-ABL1. SH/EAHP, 2017.
68. Li S, Xu J, Wang W, Konoplev S, Medeiros LJ, Bueso-Ramos CE, Yin CC. Chronic myeloid leukemia in myeloid blast phase with inv16(p13.1q22)/CBFB-MYH11. SH/EAHP, 2017.
69. Yin CC, Khour JD, Xu J, Lin P, You MJ, Muzzafar T, Bueso-Ramos CE, Medeiros LJ, Li S. Acute myeloid leukemia with clonal evolution upon progression. SH/EAHP, 2017.
70. Ruiz-Cordero R, Chen W, Floyd K, Rodriguez S, Galbincea J, Barkoh B, Routbort M, Luthra R, Singh R, Hatfield D, Kanagal-Shamanna R, Yin CC, Zuo Z, Loghavi S, Ok C, Medeiros LJ, Patel KP. Breaking the turnaround time barrier in next generation sequencing-based clinical mutation profiling using an integrated workflow and informatics approach. Mol Diagn, 2017.
71. Kanagal-Shammana R, Luthra R, Routbort MJ, Singh R, Floyd K, Abraham R, Hain S, Yin CC, Zuo Z, Ok C, Loghavi S, Medeiros LJ, Patel KP. Multi-platform-based comprehensive molecular analysis of hematological malignancies for somatic mutations, copy number changes and translocations in routine clinical testing. Mol Diagn, 2017.
72. Pemmaraju N, Kantarjian H, Khoury J, O'Brien S, Cortes J, Garcia-Manero G, Jabbour E, Jain N, Alvarado Y, Duvic M, Aung P, Qazillbash M, Yin CC, Konoplev S, Patel KP, PIerce S, Brandt M, Konopleva M. Long-term outcomes in patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN). Blood, 2017.
73. Veletic I, Manshouri T, Yin CC, Newberry K, Verstovsek S, Estrov Z. Neoplastic monocyte-derived osteoclasts are highly proliferative, but sub-functional in MPN-associated myelofibrosis. Blood, 2017.
74. Ok CY, Singh R, Luthra R, Hatfield D, Floyd K, Loghavi S, Kanagal-Shamanna R, Zuo Z, Yin CC, Routbort MJ, Kantarjian HM, Medeiros LJ, Patel KP. EndLeukemia Assay v1: Enabling NGS-based comprehensive routine molecular profiling of leukemias in routine clinical care. Blood, 2017.
75. Xu J, Medeiros LJ, Yin CC, Tang G, Lin P, Li S. Triple-hit blastoid mantle cell lymphoma presenting like acute leukemia. SH/EAHP, 2017.
76. Kurt H, Yin CC, Bueso-Ramos CE, Wang SA. Myelodysplastic syndrome with myelofibrosis. SH/EAHP, 2017.
77. Hu B, Patel K, Wang X, Chen H, Thompson PA, Keating MJ, Birger JA, Jain N, Ferrajoli A, Bose P, Estrov Z, Luthra R, Kanagal-Shamanna R, Medeiros LJ, Yin CC, Zuo Z, Ok CY, LOghave S, Wierda WG. Standardized targeted sequencing of 29 genes with recurrent mutations in chronic lymphocytic leukemia (CLL) helps to better define clinical correlates and genomic hotspots. Blood, 2017.
78. Yin CC. Clinical applications of immunoglobulin expression in acute myeloid leukemia. J Blood Disorder & Transfusion, 2016.
79. Yin CC. Clinical significance of CD5 expression in B-cell lymphomas. J Blood Disorder & Transfusion, 2016.
80. Issa GC, Kantarjian HM, Yin CC, Ravandi F, Garcia-Manero G, Thomas DA, Cortes JE, Short NJ, Sasaki K, Pierce S, Verstovsek S, Kadia TM, Borthakur G, O'Brien SM, Jabbour E. Prognostic impact of pre-treatment cytogenetics in adult acute lymphoblastic leukemia. 2016 ASCO Annual Meeting, 2016.
81. Hodjat P, Priyanka P, Ghosh K, Thakral B, Patel KP, Routbort M, Kanagal-Shamanna R, Yin CC, Zuo Z, Luthra R, Muzzafar TM. Mutation analysis in 35 cases of newly diagnosed therapy related acute myeloid leukemia by next generation sequencing (NGS): a clinico-pathologic correlation. 2016 ASCO Annual Meeting, 2016.
82. Xu J, Saksena A, Desai P, Lin P, Yin CC, Tang G, You J, Medeiros LJ, Li S. CD30 Expression and Its Prognostic Significance in De Novo Diffuse Large B Cell Lymphoma Treated with Rituximab-EPOCH. Mod Pathol, 2016.
83. Pina-Oviedo S, Medeiros LJ, Li S, Alayed K, Yin CC. Langerhans cell histiocytosis in patients with concurrent lymphoma: a reactive Langerhans cell histiocytosis in patients with concurrent lymphoma: a reactive process without evidence of BRAF mutation. Mod Pathol, 2016.
84. Thakral B, Desai P, Lin P, Yin CC, Tang G, Hu S, Khoury JD, Medeiros LJ, Li S. Prognostic significance of CD5 expression in diffuse large B-cell lymphoma in patients treated with Rituximab-EPOCH. Mod Pathol, 2016.
85. Ghosh K, Hidjat P, Priyanka P, Thakral B, Patel KP, Routbort M, Kanagal-Shamanna R, Yin CC, Zuo Z, Luthra R, Muzzafar T. Mutation analysis in 117 cases of newly diagnosed myelodysplastic syndrome: IPSS-R high and very high risk by next generation sequencing: a clinico-pathologic correlation. Mod Pathol, 2016.
86. Hodjat P, Priyanka P, Ghosh K, Thakral B, Patel KP, Routbort M, Kanagal-Shamanna R, Yin CC, Zuo Z, Luthra R, Muzzafar TM. Mutation analysis in 50 cases of newly diagnosed acute myeloid leukemia arising from myelodysplastic syndrome by next generation sequencing: a clinico-pathologic correlation. Mod Pathol, 2016.
87. Hodjat P, Priyanka P, Ghosh K, Thakral B, Patel KP, Routbort M, Kanagal-Shamanna R, Yin CC, Zuo Z, Luthra R, Muzzafar TM. Mutation analysis in 8 cases of newly diagnosed acute myeloid leukemia arising from myeloproliferative neoplasms by next generation sequencing: a clinico-pathologic correlation. Mod Pathol, 2016.
88. Hodjat P, Priyanka P, Ghosh K, Thakral B, Patel KP, Routbort M, Kanagal-Shamanna R, Yin CC, Zuo Z, Luthra R, Muzzafar TM. Mutation analysis in 122 cases of newly diagnosed normal karyotype acute myeloid leukemia by next generation sequencing: a clinico-pathologic correlation. Mod Pathol, 2016.
89. Hodjat P, Priyanka P, Ghosh K, Thakral B, Patel KP, Routbort M, Kanagal-Shamanna R, Yin CC, Zuo Z, Luthra R, Muzzafar TM. Mutation analysis in 45 cases of newly diagnosed acute myeloid leukemia with recurrent cytogenetic abnormalities by next generation sequencing: a clinico-pathologic correlation. Mod Pathol, 2016.
90. Pina Oviedo S, Medeiros LJ, Li S, Alayed K, Yin CC. Langerhans cell histiocytosis in patients with concurrent lymphoma. Houston Society of Clinical Pathologists, 2016.
91. Yin CC, Li S, Xu J, Lin P, Medeiros LJ, Abruzzo LV. Mantle cell lymphoma, blastoid variant, arising from classical mantle cell lymphoma. EAHP 2016 Lymphoma Workshop, 2016.
92. Yin CC, Ketterling RP, Medeiros LJ, Abruzzo LV. Chronic lymphocytic leukemia/small lymphocytic lymphoma with isolated t(2;14)(p13;q32). EAHP 2016 Lymphoma Workshop, 2016.
93. Yin CC, Li S, Hu S, Zuo Z, Lin P, Konoplev S, Khoury JD, Young KH, Medeiros LJ, Li Y. CD5-positive follicular lymphoma with large cell transformation. EAHP 2016 Lymphoma Workshop, 2016.
94. Quesada AE, Hu Z, Routbort MJ, Patel KP, Luthra R, Loghavi S, Zuo Z, Yin CC, Kanagal-Shamanna R, Wang SA, Jorgensen J, Medeiros LJ, Ok CY. Mixed phenotype acute leukemia contains heterogeneous genetic mutations by next-generation sequencing. J Mol Diagn, 2016.
95. Saksena A, Miao Y, Lin P, Wang M, Yin CC, Li J, Medeiros LJ, Li S. CD5-negative mantle cell lymphoma: clinicopathologic correlations and outcome in 58 cases. Blood, 2016.
96. Short NJ, Jabbour E, Sasaki K, Ko H, Ravandi F, Yin CC, Khouri MR, Cortes JE, Garris R, O'Brien S, Patel K, Garcia-Manero G, Thomas D, Daver N, Naqvi K, Bose P, Jain N, Konopleva M, Kantarjian H. Additional chromosomal abnormalities in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with tyrosine kinase inhibitors: differential outcomes according to type of chromosomal abnormality. Blood, 2016.
97. Quesada AE, Desai P, Tang G, Westin J, Lin P, Seegmiller A, Yin CC, Wang W, Xu J, Miranda RN, Reddy N, Medeiros LJ, Li S. MYC copy number aberrancies predict a worse prognosis in patients with diffuse large B-cell lymphoma. Blood, 2016.
98. Veletic I, Manshouri T, Prijic S, Yin CC, Bove IV JE, Zhang Y, Verstovsek S, Estrov Z. Multiplex quantitative imaging analysis of bone-remodeling cells in patients with myelofibrosis. Blood, 2016.
99. Patel KP, Singh R, Roubbort MJ, Kanagal-Shamanna R, Yin CC, Lu X, Pierce S, Jain N, Keating M, Kantarjian H, Medeiros LJ, Luthra R, Wierda W. Routine clinical testing for actional mutations in CLL using EndCLL Assay V1: The initial MD Anderson Experience. Blood, 2016.
100. Lin P, Bueso-Ramos C, Yin CC, Miranda R, Hu Z. Histiocytic/monocytic sarcoma. EAHP 2016 Lymphoma Workshop, 2016.
101. Yin CC. Clinical application of molecular testing in myeloid leukemia. J Blood Disorder & Transfusion, 2016.
102. Yin CC. Molecular monitoring of chronic myelogenous leukemia. J Blood Disorder & Transfusion, 2016.
103. Loghavi S, Routbort MJ, Kanagal-Shamanna R, Wang SA, Khoury J, Ok CY, Yin CC, Singh RR, Zuo Z, Bueso-Ramos CE, Medeiros LJ, Luthra R, Patel KP. Myeloid neoplasms with recurrent GNAS mutations. J Mol Diagn, 2016.
104. Masarova L, Yin CC, Cortes JE, Konopleva M, Borthakur G, Newberry KJ, Kantarjian HM, Bueso-Ramos CE, Verstovsek S. Histomorphological responses after therapy with pegylated interferon alpha-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV). Blood, 2016.
105. Aung FM, Lichtiger B, Rondon G, Yin CC, Alousi A, Ahmed S, Andersson B, Bashir Q, Ciurea S, Hosing C, Jones R, Kebriaei P, Khouri I, Nieto Y, Betul O, Parmar S, Qazibash M, Shah N, Sphall E, Champlin RE, Popat UR. Pure red cell aplasia in major mismatched allogeneic hematopoietic stem cell transplantation is associated with severe pancytopenia. 20th Congress of European Hematology Association, Vienna, Austria, June 11-14, 2015, 2015.
106. Aye LL, DO1 Loghavi S, Young KH, Medeiros J, Yin CC, Routbort M, Liang M, Hudnall D, Bueso-Ramos C, Brynes R. Pre-leukemic phase Of chronic myelogenous leukemia: morphologic and immunophenotypic characterization of 5 cases. Arch Pathol & Lab Med, 2015.
107. Li Y, Hu S, Zuo Z, Hong M, Lin P, Li S, Konoplev S, Wang Z, Khoury J, Young K, Medeiros LJ, Yin CC. CD5-positive follicular lymphoma: clinicopathologic correlation and outcome in 88 patients. Mod Pathol 28(Supple 2):359A, 2015.
108. Loghavi S, Al-Ibraheemi A, Zuo Z, Wang S, Garcia-Manero G, Kantarjian H, Yin CC, Miranda R, Medeiros CC, Bueso-Ramos C, Khoury J. De novo myelodysplastic syndromes with fibrosis exhibit an increased frequency of TP53 mutations and overexpression. Mod Pathol 28(Supple 2):361A, 2015.
109. Rich A, Al D, Wang W, You MJ, Yin CC, Bueso-Ramos C, Medeiros LJ, Hu S. Pediatric chronic myelogenous leukemia in tyrosine kinase inhibitor era. Mod Pathol 28(Supple 2):373A, 2015.
110. Shen Q, Li S, Chen M, Song J, Lu G, Tang G, Hu S, Wang X, Lin P, Medeiros LJ, Yin CC. Acute myeloid leukemia/myelodysplastic syndrome with t(3;5): clinicopathologic, immunophenotypic, and molecular genetic features of 16 cases. Mod Pathol 28(Supple 2):377A, 2015.
111. Ghosh K, Hodjat P, Priyanka P, Thakral B, Patel K, Routbort M, Kanagal-Shamana K, Yin CC, Zuo Z, Luthra R, Muzzafar T. Mutation analysis in 200 cases of newly diagnosed myelodysplastic syndrome by next generation sequencing: association with established prognostic variables. Blood, 2015.
112. Hodjat P, Ghosh K, Priyanka P, Thakral B, Patel K, Routbort M, Kanagal-Shamanna K, Yin CC, Luthra R, Muzzafar T. Mutation analysis in 276 cases of newly diagnosed acute myeloid leukemia by next generation sequencing: association with established prognostic variables. Blood, 2015.
113. Saksena A, Desai P, Zuo Z, Xu J, Lin P, Seegmiller A, Yin CC, Thang G, Miranda RN, Jorgensen JL, Reddy N, Medeiros LJ, Li S. MYC/BCL2 Double Hit Lymphoma: What Really Matters. Blood, 2015.
114. Issa GC, Kantarjian HM, Yin CC, Sasaki K, Garcia-Manero G, DiNardo C, Takahashi K, Ravandi F, Cortes JE, Daver N, Kadia T, Verstovsek S, Pierce S, Jabbour E. Prognostic implications of pre-treatment hypodiploidy and complex cytogenetics in adult patients with acute lymphocytic leukemia (ALL) treated with Hyper-CVAD. Blood, 2015.
115. Wang XJ, Medeiros LJ, Thompson MA, Lin P, Yin CC, Abel TW, Li S. MYC/BCL2 double-hit (DHL) and MYC aberrations correlate with a worse outcome within MYC/BCL2 protein double-positive (DPL) high-grade B-cell lymphoma. Mod Pathol 27(Supple 2):384A, 2014.
116. Tang G, Wang SA, Wang XI, Yin CC, Lu V, Lu G. Silent clonal cytogenetic abnormalities arising in patients treated for lymphoid neoplasms. Mod Pathol 27(Supple 2):381A, 2014.
117. Lu G, Yin CC, Abruzzo LV, Luthra R, Abraham R, Kanagal-Shammanna R, Medeiros LJ. Acquired silent cytogenetic clones arising in patients treated successfully for lymphoma. Mod Pathol 26(suppl 2):343A, 2013.
118. Jaso JM, Lu VW, Yin CC, Zhao M, Abruzzo L, You MJ, Medeiros LJ, Lu G. B-lymphoblastic leukemia with t(14;19)(q32;p13.1) involves IGH@ and EPOR genes and is associated with an aggressive clinical course. Mod Pathol 26(suppl 2):335A, 2013.
119. Wang XI, Patel K, Lin P, Zuo Z, Bueso-Ramos CE, Luthra R, Medeiros LJ, Yin CC. Clinicopathologic and molecular genetic features of de novo myeloid sarcoma. Mod Pathol 26(suppl 2):365A, 2013.
120. Wang XI, Routbort M, Patel K, Bueso-Ramos CE, Yin CC. Acute myeloid leukemia arising from myelodysplastic syndrome, diploid karyotype, with mutations in FLT3, NPM1, DNMT3A and TP53. Society for Hematopathology/European Association for Haematopathology 2013 Workshop:355, 2013.
121. Wang XI, Patel K, Routbort M, Zuo Z, Lin P, Bueso-Ramos CE, Luthra R, Medeiros LJ, Yin CC. De novo myeloid sarcoma with subsequent AML development, diploid karyotype and mutations in IDH2, TP53 and GNAS. Society for Hematopathology/European Association for Haematopathology 2013 Workshop:357, 2013.
122. Wang XI, Bai B, Lu G, Hu S, Yin CC. t(1;3)(p36;p21) as the sole clonal abnormality in refractory acute myeloid leukemia. Society for Hematopathology/European Association for Haematopathology 2013 Workshop:320, 2013.
123. Yabe M, Bai B, Wang XI, Zuo Z, Yin CC. Novel Chromosomal Aberration, t(2;16)(p21;p11.2),t(11;14)(p13;p11.2), as evidence of clonal evolution in a case of relapsed acute myeloid leukemia. Society for Hematopathology/European Association for Haematopathology 2013 Workshop:318, 2013.
124. Hu S, Young K, Medeiros LJ, Yin CC. T-lymphoblastic lymphoma with eosinophilia and t(8;13)(p11.2;q12). Society for Hematopathology/European Association for Haematopathology 2013 Workshop:317, 2013.
125. Zuo Z, Bueso-Ramos CE, Yin CC, Medeiros LJ. Acute myeloid leukemia with monocytic differentiation. Society for Hematopathology/European Association for Haematopathology 2013 Workshop:186, 2013.
126. Lu G, Schulz RA, Bueso-Ramos CE, Cortes JE, Wang HI, Medeiros LJ, Yin CC. Acute myeloid leukemia with double-hit genetic abnormalities of the FLT3 gene. Society for Hematopathology/European Association for Haematopathology 2013 Workshop:360, 2013.
127. Alayed K, Patel K, Zuo Z, Verma S, Galbincea J, Cason RC, Luthra R, Medeiros LJ, Yin CC. BRAF mutation occurs more frequently in pulmonary Langerhans cell histiocytosis and in younger patients. J Mol Diagn 15(6):858-859, 2013.
128. Dinardo CD, Daver N, Jain N, Pemmaraju N, Bueso-Ramos CE, Yin CC, Pierce S, Jabbour E, Quintas-Cardama A, Cortes J, Kantarjian H, Garcia-Manero G, Verstovsek S. Myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN, U): Natural history and clinical outcome by therapeutic approach. Blood, 2013.
129. Kanagal-Shammanna R, Bueso-Ramos CE, Medeiros LJ, Yin CC. Acute myeloid leukemia with isolated i(17q) and MDM4 mutation. Society for Hematopathology/European Association for Haematopathology 2013 Workshop, 2013.
130. Hoehn D, Lu G, Konoplev S, Bueso-Ramos CE, Zuo Z, Medeiros LJ, Yin CC. t(15;17)(q24.1;q21.2)/PML-RARA in blast phase of chronic myelogenous leukemia: a rare form of clonal evolution. Society for Hematopathology/European Association for Haematopathology 2013 Workshop, 2013.
131. Ng D, Liang S, Tian T, Yin CC, Young KH, Jorgensen J, Hoehn D, Sargent R, Miranda R, Amin H, You J, Schlette E, Lin P. Assessing minimal disease in plasma cell neoplasms: A comparison between multicolor flow cytometry and immunohistochemistry. Mod Pathol 25(suppl 2):357A, 2012.
132. Warren M, Luthra R, Yin CC, Ravandi F, Medeiros LJ, Zuo Z. Clinical impact of change of FLT3 mutation status in acute myeloid leukemia patients. Mod Pathol 25(suppl 2):379A, 2012.
133. Li S, Yin CC, Medeiros LJ, Lu G, Lin P. Myelodysplastic syndrome/acute myeloid leukemia with t(3;21)(q26;q22) are commonly therapy related diseases associated with poor outcome. Mod Pathol 25(suppl 2):351A, 2012.
134. Chen SS, Yin CC, Konoplev SN, Young KH, Muddasani R, Medeiros LJ, Lu G. Acquired trisomy 21 as a sole chromosomal abnormality is associated with a heterogeneous group of myeloid neoplasms and variable disease outcome. Mod Pathol 25(suppl 2):329A, 2012.
135. Yin CC, Hu S, Medeiros LJ, Lu G. Isolated clonal trisomy 13 in Philadelphia chromosome-negative metaphases in patients with chronic myelogenous leukemia. Mod Pathol 25(suppl 2):383A, 2012.
136. Kanagal-Shamanna R, Yin CC, Muddasani R, Luthra R, Cortes J, Zuo Z, Chen SS, Hu S, Abruzzo LV, Miranda RN, Medeiros LJ, Lu G. Acute myeloid leukemias with translocations involving 4q12/PDGFRA: Frequent involvement of ETV6. Mod Pathol 25(suppl 2):346A, 2012.
137. Jaso J, Yin CC, Jabcuga CE, Medeiros LJ, Chen L. CD5-positive nodal marginal zone lymphoma: A clinicopathologic study of 7 cases. Mod Pathol 25(suppl 2):344A, 2012.
138. Zhou Y, Routbort M, Young KH, Wang S, Hoehn D, Tang G, Bueso-Ramos C, Yin CC, Miranda RN, Medeiros LJ, Lin P. Negative TdT expression predicts adverse treatment outcome in T-lymphoblastic leukemia/lymphoma in adults. Mod Pathol 25(suppl 2):386A, 2012.
139. Lee HC, Yin CC, Qazilbash MH, Wang XI, Lu V, Lu G. Acquired therapy-related cytogenetic clones in patients treated for multiple myeloma. Blood, 2012.
140. Jabbour EJ, Kantarjian HM, Yin CC, Ravandi F, Cortes JE, Garcia-Manero G, Ghanem H, Kadia TM, Faderl S, O'Brien S, Mathisen MS, Brandt M, Pemmaraju N, Thomas DA, Bass J, Borthakur G. Dynamics of molecular response in patients with acute myeloid leukemia with core binding factor abnormalities treated with high-dose cytarabine regimen. Blood, 2012.
141. Hoehn D, Zhou Y, Bueso-Ramos CE, Lun G, Zuo Z, Konoplev S, Hsu B, Medeiros LJ, Yin CC. t(15;17)(q22;q21)/PML-RARA in blast phase of chronic myelogenous leukemia: a unique clonal evolution. 2011 ASCP Annual Meeting/WASPaLM World Congress, Las Vegas, NV, 2011.
142. Li S, Zuo Z, Bueso-Ramos CE, Yin CC. FLT3 mutation in a case of T-lymphoblastic leukemia with aberrant CD117 expression. 2011 ASCP Annual Meeting/WASPaLM World Congress, Las Vegas, NV, 2011.
143. Bai B, Harper E, Cheong SH, Lovshe D, Yang S, Yin CC. New clonal chromosome aberrations in a case of relapsed acute myeloid leukemia. Association of Genetic Technologists 36th Annual Meeting, 2011.
144. George AM, Zuo Z, Hu P, Yin CC. Impact of numbers of FLT3 internal tandem duplication on clinicla outcome of patients with acute myeloid leukemia and diploid karyotype. UT MD Anderson Cancer Center Trainee Research Day, 2011.
145. Yin CC, Lu G, Medeiros LJ, Feng X, Keating MJ, Abruzzo LV. Del(20q) in patients with chronic lymphocytic leukemia is associated with prior chemotherapy, atypical morphology, ZAP70 expression and unmutated IGVH genes. Mod Pathol 24 (suppl 1):331A, 2011.
146. Jasso J, Chen L, Lin P, Li S, Miranda RN, Medeiros LJ, Yin CC. CD5-positive MALT lymphoma: a clinicopathologic study of 9 cases. Mod Pathol 24 (suppl 1):302A, 2011.
147. Shamanna RK, Yin CC, Lu G, Medeiros LJ, Nguyen M, Hoehn D, Garcia-Manero G, Vadhan-Raj S, Bueso-Ramos C. Myelodysplastic/myeloproliferative neoplasm with isolated isochromosome 17q: an aggressive clinical syndrome with prominent multilineage dysplasia, increased blasts and wild type NPM1. Mod Pathol 24 (suppl 1):304A, 2011.
148. Li S, Feng X, Lin P, Konoplev S, Medeiros LJ, Yin CC. Extranodal NK/T-cell lymphoma, nasal type, a retrospective study of 50 cases from the United States. Mod Pathol 24 (suppl 1):307A, 2011.
149. Ma D, Luthra R, Chen SS, Yin CC, Sargent RL, Patel KP, Medeiros LJ, Zuo Z. RAS mutation analysis in 9334 solid and hematopoietic malignancies. Mod Pathol 24 (suppl 1):394A, 2011.
150. Shamanna RK, Miranda R, Yin CC, Bueso-Ramos C, Muddasani R, Medeiros LJ, Lu G. Isolated deletion of chromosome 20q in de novo myelodysplastic syndrome is associated with favorable prognosis and wild type FLT3 or RAS. Mod Pathol 24 (suppl 1):304A, 2011.
151. Li S, Medeiros LJ, Fayad L, Lennon P, Yin CC, Lin P. "Double hit" high-grade B-Cell lymphomas: an aggressive disease with heterogeneous histologic features and clinical outcome. Mod Pathol 24 (suppl 1):306A, 2011.
152. Chen SS, Zuo Z, Luthra R, Lu G, Borthakur G, Wang S, Medeiros LJ, Yin CC. Double mutations of NRAS and KRAS in acute myeloid leukemia and myelodysplastic syndrome are associated with monocytic differentiation, multilineage dysplasia, increased myeloblasts and prior chemotherapy. Mod Pathol 24 (suppl 1):290A, 2011.
153. Zuo Z, Greaves WO, Luthra R, Sargent R, Chen SS, Galbincea J, Medeiros LJ, Yin CC. KIT mutation is rare in acute myeloid leukemias, almost always involves exon 17, and occurs predominantly in AML with t(8;21)(q22;q22). J Mol Diagn 13(6):729, 2011.
154. Konoplev SK, Yin CC, Kornblau SM, Kantrajian HM, Konopleva M, Andreeff M, Lu G, Zuo Z, Luthra R, Medeiros LJ, Bueso-Ramos CE. NPM1 mutation occurs in a subset of Ph+ AML suggesting that this entity is distinct from CML in myeloid blast phase. J Mol Diagn 13(6):731, 2011.
155. Barkoh B, Do D, Hai S, Patel K, Yin CC, Medeiros LJ, Luthra R. High resolution melting analysis as an upfront cost effective screening method for the detection of low frequency KIT exon 17 mutations in acute myeloid leukemia in clinical laboratory. J Mol Diagn 13(6):732, 2011.
156. Yang Y, Gao X, Han X, Huang X, Liu Q, Zhang YH, Yin, CC, Chen L, You MJ. Inactivation of INK4a/ARF accelerates the development of PTEN deficient T-ALL. Blood 116(21):1706, 2010.
157. Jabbour E, Kantarjian HM, Jones D, Yin, CC, Burton E, cortes J. Characteristics and outcome of patients with V299L BCR-ABL kinase domain mutation after therapy with tyrosine kinase inhibitors. Blood 116(21):1404, 2010.
158. Han JY, Mulligan S, Hu P, Lennon A, Yin, CC, Lin P. MiRNA-150 and MiRNA-155 expression patterns are distinct in acute myeloid leukemia versus blast phase of chronic myelogenous leukemia associated with inv(3)(q21q26). Association of Genetic Technologists 2010 Annual Meeting, 2010.
159. Qiu X, Sun X, He Z, Lin P, You MJ, Chen L, Dai CW, Yin, CC. Expression of immunoglobulin gene in myeloblasts from patients with acute myelogenous leukemia and its distinct V K J K recombination pattern. Cancer Res 70(8(supplement)):2745-2745, 2010.
160. Gurevich I, Zhao C, Yin, CC, Han X, Lin P, Gao X, Nguyen MH, Pan E, Medeiros LJ, Bueso-Ramos C, You MJ. Aberrant nuclear and loss of PTEN expression in acute myeloid leukemia. Mod Pathol, 2010.
161. Sun J, Chen S, Cui W, Yin, CC, Medeiros LJ, Lu G. Chromosome 20q deletion - a recurrent cytogenetic abnormality in chronic myelogeneous leukemia patients in remission. Mod Pathol, 2010.
162. Dai A, Zhao C, Yin CC, Chen L, Sun X, Dave S, Huang X, Zhang YH, Han X, You MJ. Hypermethylation of DBCCR1 gene in acute myeloid leukemia. Proceedings of the 101th Annual Meeting of the American Association for Cancer Research, 2010.
163. He Z, Yin, CC. Bacteria could promote proliferation of AML cells. Proceedings of the 101th Annual Meeting of the American Association for Cancer Research, 2010.
164. Qiu X, Lin P, Sun X, You MJ, Medeiros LJ, Yin, CC. Detection of mono/oligo clonal IgH gene rearrangements and characterization of associated clinicopathologic features in acute myeloid leukemia. Mod Pathol 22:281, 2009.
165. Qiu X, Zheng J, Huang J, Mao Y, Zhu X, Yin, CC. Immunoglobulin gene transcripts from human epithelial cancer cells have distinct VHDJH or VKJK recombination. Proceedings of the 100th Annual Meeting of the American Association for Cancer Research. Denver, CO, 2009.
166. Littlejohn M, Lennon A, Hu P, Im W, Pepper R, Lin P, Medeiros LJ, Yin, CC. FISH analysis of BCL-2 and BCL-6 rearrangements in germinal center and non-germinal center types of diffuse large B-cell lymphoma in China. Texas Association of Clinical Lab Scientists Annual Meeting, Houston, TX, 2009.
167. Im W, Yin, CC, Littlejohn M, Hu P, Lin P, Medeiros LJ, Lennon A. MYC rearrangements in diffuse large B-cell lymphoma cases from China. Texas Association of Clinical Lab Scientists Annual Meeting, Houston, TX, 2009.
168. Littlejohn M, Lennon A, Hu P, Im W, Pepper R, Lin P, Medeiros LJ, Yin, CC. FISH analysis of BCL-2 and BCL-6 rearrangements in germinal center and non-germinal center types of diffuse large B-cell lymphoma in China. Association of Genetic Technologists Annual Meeting, Houston, TX, 2009.
169. Im W, Yin, CC, Littlejohn M, Hu P, Lin P, Medeiros LJ, Lennon A. MYC rearrangements in diffuse large B-cell lymphoma cases from China. Association of Genetic Technologists Annual Meeting, Houston, TX, 2009.
170. Littlejohn M, Lennon A, Hu P, Im W, Pepper R, Lin P, Medeiros LJ, Yin, CC. FISH analysis of BCL-2 and BCL-6 rearrangements in germinal center and non-germinal center types of diffuse large B-cell lymphoma in China. UT MD Anderson Cancer Center Trainee Recognition Day, Houston, TX, 2009.
171. Im W, Yin, CC, Littlejohn M, Hu P, Lin P, Medeiros LJ, Lennon A. MYC rearrangements in diffuse large B-cell lymphoma cases from China. UT MD Anderson Cancer Center Trainee Recognition Day, Houston, TX, 2009.
172. Yin, CC, Medeiros LJ, Lin P. Marginal zone B-cell lymphoma with marked plasmacytic differentiation. Society for Hematopathology/European Association for Hematopathology Workshop. Cleveland, OH, 2009.
173. Zhao C, Dai A, Chen L, Sun X, Han X, Yin, CC, You MJ. Epigenetic Inactivation of DBC1 in Acute Myeloid Leukaemia. Blood 114:4429, 2009.
174. Li T, Medeiros LJ, Lin P, Yin H, Guo H, Yin, CC.. Immunohistochemical profile of diffuse large B-Cell lymphoma in China. Mod Pathol 21 (suppl 1s):261A, 2008.
175. You MJ, Ku PT, Yin, CC, Bargmann W, Wong KK, Medeiros LJ, Bose HR, Dorfman DM.. Expression of Golgin-84 in non-Hodgkin lymphomas and plasma cell myelomas. Mod Pathol 21 (suppl 1s):282A, 2008.
176. Konoplev S, Nguyen M, Huang X, Rassidakis GZ, Garcia-Manero G, Yin CC, Amin H, Schlette E, Lin P, Vega-Vazquez F, Admirand J, Huh Y, You J, Jorgensen JL, Kantarjian HM, Medeiros LJ, Bueso-Ramos C.. Cytoplasmic expression of nucleophosmin does not predict favorable prognosis in AML patients. Mod Pathol 21 (suppl 1s):260A, 2008.
177. Lu, G, Yin, CC, Medeiros, LJ, Abruzzo, LV. Del (15q) is a recurrent cytogenetic "minor route" abnormality in evolving CML. Leukemia, 2008.
178. Mallampati S, Sun B, Gong Y, Wang E, You MJ, Amin HM, Ma Y, Shen H, Zweidler-McKay P, Jones D, Yin CC, Glassman A, Kantarjian HM, Issa JP, Arlinghaus RB, Sun X. Rooting into the soil, a model for the role of Sox4 in leukemia. Blood 112:3794, 2008.
179. Liu Q, Gao X, Yin CC Ling C, You MJ. Resveratrol inhibits proliferation and induces apoptosis of mouse Pten null T-cell acute lymphocytic leukemia cells. Blood 112:3967, 2008.
180. Yin CC, Medeiros LJ, Barron LL, Abruzzo LV.. Chronic lymphocytic leukemia/small lymphocytic lymphoma with t(2;14)(p13;q32) is often associated with atypical morphologic features, unmutated IgVH genes and aggressive clinical course. Mod Pathol 20 (suppl 2s):265A, 2007.
181. Zhang C, Li B, Talpur R, Yin CC, Duvic M. Biomarkers of vorinostat resistance in cutaneous T cell lymphoma. Blood 110:1381, 2007.
182. Jones D, Yin CC. Chronic myeloid leukemia in blast transformation with shifts in genetically related but distinct CML clones following sequential introduction of effective bcr-abl kinase inhibitors. Society for Haematopathology and European Association for Haematopathology Workshop. Indianapolis, IA, 2007.
183. Yin CC, Medeiros LJ, Lin P, Cromwell C, Mehta A, Jones D, Luthra R, Abruzzo LV.. Sequence analysis proves clonal identity in five patients with typical and blastoid mantle cell lymphoma. Mod Pathol 19 (suppl 1s):253A, 2006.
184. Chen L, Guo J, Jones D, Luthra R, Yin CC, Lin P. Clinical implications of quantitative and qualitative post-treatment detection of AML1-ETO in AML. 95th Annual Meeting of the United States and Canadian Academy of Pathology. Atlanta, GA, 2006.
185. Merzianu M, Yin CC, Lin P, Glassman AB, Medeiros LJ, Huh Y. inv(16)(p13q22) in blast phase of chronic myelogenous leukemia – Clinical, morphologic, cytogenetic and molecular study of 5 cases. 94th Annual Meeting of the United States and Canadian Academy of Pathology. San Antonio, TX, 2005.
186. Valbuena JR, Rassidakis GZ, Estey E, Luthra R, Yin CC, Medeiros LJ, Jones D. Ras mutations are associated with monocytic differentiation in myeloid leukemias and are an adverse prognostic factor in chronic myelomonocytic leukemia (CMML). Mod Pathol 18 (suppl 1s):255A, 2005.
187. Yin CC, Glassman AB, Lin P, Valbuena JR, Jones D, Luthra R, Medeiros LJ. Morphologic, cytogenetic and molecular abnormalities in therapy-related acute promyelocytic leukemia. Mod Pathol 18 suppl 1s:258A, 2005.
188. Yin CC, Luthra R, Galbincea J, Cortes J, Jones D. A Pyrosequencing method for quantitation of mutated bcr-abl transcripts in chronic myelogenous leukemia patients with imatinib resistance. Mod Pathol 18 (suppl 1s):258A, 2005.
189. Yin CC, Cortes J, Glassman AB, Valbuena JR, Hayes K, Kantarjian H, Jones D.. AML1-MDS1-EVI1 activation through t(3;21)(q26; q22): An aggressive syndrome of myeloid blast transformation following antimetabolite therapy. Mod Pathol 18 (suppl 1s):259A, 2005.
190. Vega CA, Luthra R, Yin CC, Verstovsek S, Kantarjian H, Jones D.. Quantitative detection of the V617F mutation in JAK2 and its role in the diagnosis of chronic myeloproliferative disorders. J Mol Diagn 7:666, 2005.
191. Yin CC, Cortes J, Luthra R, Barkoh B, Giles F, Kantarjian H, Jones D.. Tandem DNA and RNA quantitative sequencing analysis reveals differential effects of changes in therapy on mutated and unmutated bcr-abl in chronic myelogenous leukemia. Trainee Recognition Day, UT MD Anderson Cancer Center. Houston, TX, 2005.
192. Yin CC, Luthra R, Cortes J, Reeves N, Hayes K, Glassman A, Kantarjian H, Jones D. Imatinib resistance in chronic myelogenous leukemia is frequently associated with either ABL kinase mutations or with secondary rearrangements of the BCR-ABL locus. J Mol Diagn 6:416, 2004.
193. Yin CC, Rassidakis GZ, Medeiros LJ, Bueso-Ramos C, Abruzzo LV, Handy B, Lin P.. Chronic lymphocytic leukemia/small lymphocytic lymphoma associated with IgM paraprotein – A clinicopathological study of 26 cases. Mod Pathol 17 (suppl):277A, 2004.
194. Li Y, Boyert L, Lacy M, Yin C, Horvat RT. Assessments of antimicrobial susceptibility tests and PCR-assay for detection of macrolide-resistance Streptococcus pneumoniae. American Association of Microbiology annual meeting. Orlando, FL, 2001.
195. Djavani M, Yin C, Lukashevich IS, Salvato MS. Cross-protective immunity to LCMV in mice inoculated with Lassa virus nucleoprotein. American Society for Virology 19th annual meeting. Vancouver, Canada, 2000.
196. Evans PS, Yin C, Ruckwardt T, Pauza CD. How did you know that? Antigen recognition by gamma delta T cells. Virology Series Conference. Madison, WI, 1999.
197. Yin C, Rakasz E, Evans PS, Ruckwardt T, Waterman PM, Enders PJ, Poccia T, Martini F, Malkovsky M, Pauza CD. Changes in the gamma delta T cell repertoire after HIV-1 infection. Microbial Escape Mechanisms and New Therapies of AIDS and Tuberculosis. Ischia, Italy, 1999.
198. Yin C, Schmidt DS, Pauza CD, Hideo Y, Salvato MS. High FasL predisposes rhesus macaques to rapid AIDS progression. Microbial Escape Mechanisms and New Therapies of AIDS and Tuberculosis. Ischia, Italy, 1999.
199. Yin C, Dykhuizhen M, Mitchen JL, Pauza CD, Salvato MS. Role of MHC-unrestricted cytotoxicity in AIDS pathogenesis. Keystone Symposia Conferences - HIV Pathogenesis and Treatment. Park City, Utah, 1998.
200. Yin C, Wu MS, Dykhuizen M, Mitchen JL, Pauza CD, Salvato MS. Expression of SIV envelope activates Fas and sensitizes cells to Fas-mediated apoptosis. 27th Annual Autumn Immunology Conference. Chicago, Illinois, 1998.
201. Djavani M, Yin C, Xia L, Lukashevich I, Salvato MS. Mucosal and systemic immune responses following oral immunization with live recombinant salmonella expressing Lassa fever virus nucleoprotein. American Society for Virology 16th annual meeting. Bozeman, Montana, 1997.
202. Schenkel AR, Yin C, Hinds PW, Trivedi P, Salvato MS, Pauza CD. Pertussis toxin treatment increases survival of SIV infected rhesus macaques. Keystone Symposia Conferences - AIDS Pathogenesis. Keystone, Colorado, 1997.
203. Yin C, Wu MS, Johnson EG, Pauza CD, Salvato MS. Role of MHC-unrestricted cytotoxicity in AIDS pathogenesis. Keystone Symposia Conferences - AIDS Pathogenesis. Keystone, Colorado, 1997.
204. Schenkel AR, Yin C, Pauza CD. Inhibition of pertussis toxin on SIV infection. Third Immunology Conference, University of Wisconsin-Madison. Madison, WI, 1996.
205. Yin C, Salvato MS. Effect of pertussis toxin on LCMV infection in mice. Second Immunology Conference, University of Wisconsin-Madison. Madison, WI, 1995.
206. Zhang BX, Yin C. The inhibitory effect of human LAK cells on tumorigenicity of autologous cancers in nude mice. Proceedings of the Third National Symposium of Experiment and Research of Immunodeficient Animals. Shanghai, China, 1990.
207. Zhang BX, Yin C. Functional and phenotypic study of tumor-infiltrating lymphocytes cultured in vitro. The Fifth National Conference of Pathology. Chengdu, China, 1990.

Book Chapters

1. Li S, Yin CC. Myelodysplastic Syndrome. In: Precision Molecular Pathology of Myeloid Neoplasms. Springer, 2017.
2. Auerbach A, Yin CC. Follicular Lymphoma. In: Diagnostic Pathology: Molecular Oncology. Amirsys/Elsevier, 6-34, 2015.
3. Yin CC. Reactive Follicular Hyperplasia. In: Putman A, Thompson K. Non-neoplastic Pediatric Pathology. Amirsys, 11:2-7, 2014.
4. Yin CC. Reactive Paracortical Hyperplasia. In: Putman A, Thompson K. Non-neoplastic Pediatric Pathology. Amirsys, 11:8-15, 2014.
5. Yin CC. Chronic Granulomatous Lymphadenitis. In: Putman A, Thompson K. Non-neoplastic Pediatric Pathology. Amirsys, 11:68-75, 2014.
6. Yin CC. Kimura Disease. In: Putman A, Thompson K. Non-neoplastic Pediatric Pathology. Amirsys, 11:34-41, 2014.
7. Yin CC. Mantle Cell Lymphoma. In: Nose V. Diagnostic Pathology: Familial Cancer Syndromes. Amirsys, II-2:36-39, 2014.
8. Yin CC. Follicular Lymphoma. In: Nose V. Diagnostic Pathology: Familial Cancer Syndromes. Amirsys, II-2:14-23, 2014.
9. Yin CC, Jones D. Molecular Diagnostics of Myeloid Neoplasms. In: Cheng L, Zhang D. Essentials of Molecular Genetic Pathology, 2nd Edition. Springer, 865-886, 2013.
10. Yin CC. Detection and Monitoring of Minimal Residual Disease in Myeloid Neoplasms. In: Tan D, Lynch H. Principles of Molecular Diagnostics and Personalized Cancer Medicine. Lippincott Williams & Wilkins, 247-264, 2013.
11. Yin CC. Chronic Granulomatous Lymphadenitis. In: Medeiros LJ. Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys Publishing Inc, 2;2-9, 2011.
12. Yin CC. Suppurative Lymphadenitis. In: Medeiros LJ. Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys Publishing Inc, 2;10-13, 2011.
13. Yin CC. Kimura Disease. In: Medeiros LJ. Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys Publishing Inc, 3;30-37, 2011.
14. Yin CC. Reactive Follicular Hyperplasia. In: Medeiros LJ. Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys Publishing Inc, 1;2-7, 2011.
15. Yin CC. Reactive Paracortical Hyperplasia. In: Medeiros LJ. Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys Publishing Inc, 1;8-15, 2011.
16. Yin CC. Mantle Cell Lymphoma. In: Medeiros LJ. Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys Publishing Inc, 6;42-45, 2011.
17. Yin CC. Mantle Cell Lymphoma, Blastoid Variant. In: Medeiros LJ. Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys Publishing Inc, 6;46-51, 2011.
18. Yin CC. Nodular Sclerosis Hodgkin Lymphoma. In: Medeiros LJ. Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys Publishing Inc, 4;22-31, 2011.
19. Yin CC. Mixed Cellularity Hodgkin Lymphoma. In: Medeiros LJ. Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys Publishing Inc, 4;32-37, 2011.
20. Yin CC. Lymphocyte-Depleted Hodgkin Lymphoma. In: Medeiros LJ. Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys Publishing Inc, 4;38-39, 2011.
21. Yin CC. Nodal Follicular Lymphoma. In: Medeiros LJ. Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys Publishing Inc, 6;30-41, 2011.
22. Yin CC. Primary Cutaneous Anaplastic Large Cell Lymphoma. In: Medeiros LJ. Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys Publishing Inc, 10;60-65, 2011.
23. Yin CC. Lymphomatoid Papulosis. In: Medeiros LJ. Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys Publishing Inc, 10;66-71, 2011.
24. Yin CC. Post-Transplant Lymphoproliferative Disorder: Early Lesions and Polymorphic. In: Medeiros LJ. Diagnostic Pathology: Lymph node and spleen with extranodal lymphomas. Amirsys Publishing Inc, 11;28-33, 2011.
25. Yin CC, Jones D. Myeloproliferative Neoplasms. In: Jones D. Neoplastic Hematopathology: Experimental and Clinical Approaches. Humana Press Inc, 177-192, 2010.
26. Yin CC, Jones D. Molecular Diagnostics in Myeloid Leukemias. In: Cheng L, Zhang D. Essentials of Molecular Genetic Pathology. Humana Press Inc, 675-688, 2007.
27. Zuo Z, Yin CC. Blood Cancer. In: Clinical Molecular Diagnostics. Springer.
28. Wu L, Xia M, Yin CC. Expression, function and significance of non-B-cell-derived immunoglobulin in hematologic system. In: Non-B cell Derived Immunoglobulins - the structure, characteristics and the implication on clinical medicine.